ATNX


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue
us-gaap:StatementEquityComponents
us-gaap:SharesOutstanding

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesOutstanding

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
us-gaap:ProductOrService
us-gaap:Range, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:StatementBusinessSegments, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:StatementBusinessSegments, us-gaap:ConsolidationItems
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
us-gaap:StatementGeographical
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
us-gaap:StatementGeographical, us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments
us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments

us-gaap:Revenues

us-gaap:CostOfGoodsAndServicesSold

us-gaap:GrossProfit

us-gaap:OperatingExpenses

us-gaap:CostsAndExpenses

us-gaap:ResearchAndDevelopmentExpense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:OperatingIncomeLoss

us-gaap:InterestExpense

us-gaap:InterestPaidNet

us-gaap:GainsLossesOnExtinguishmentOfDebt
us-gaap:LongtermDebtType

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
us-gaap:IncomeStatementLocation
us-gaap:PlanName, us-gaap:SubsidiarySaleOfStock

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeTaxExpenseBenefit

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents

us-gaap:NetIncomeLoss
us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:Assets
us-gaap:StatementBusinessSegments

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent
us-gaap:StatementBusinessSegments

us-gaap:InventoryNet

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:AmortizationOfIntangibleAssets

us-gaap:PropertyPlantAndEquipmentNet
us-gaap:StatementGeographical

us-gaap:Goodwill
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:LiabilitiesCurrent

us-gaap:LongTermDebtCurrent

us-gaap:AccountsPayableCurrent

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent
us-gaap:LongtermDebtType
us-gaap:LongTermDebtNoncurrent

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:StockholdersEquity

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapitalCommonStock

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:MinorityInterest

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:DepreciationDepletionAndAmortization
us-gaap:StatementBusinessSegments

us-gaap:IncreaseDecreaseInInventories

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

atnx:AccruedPurchasesOfPropertyAndEquipment
us-gaap:TypeOfArrangement
atnx:NumberOfTranches

atnx:PaymentsForLicenses
us-gaap:RelatedPartyTransactionsByRelatedParty
atnx:PercentageOfCommonStockIssuedShares
us-gaap:StatementBusinessSegments
atnx:ProvisionForChargebacks

atnx:RepaymentOfFinanceLeaseObligationsAndLongTermDebt

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
us-gaap:StatementEquityComponents

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
us-gaap:StatementEquityComponents

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
us-gaap:StatementEquityComponents

us-gaap:AmortizationOfDebtDiscountPremium

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
us-gaap:ConcentrationRiskByType, us-gaap:ConcentrationRiskByBenchmark, us-gaap:MajorCustomers, us-gaap:StatementBusinessSegments
us-gaap:ConcentrationRiskPercentage1
us-gaap:MajorCustomers, us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType, us-gaap:StatementBusinessSegments
us-gaap:TimingOfTransferOfGoodOrService, us-gaap:ProductOrService
us-gaap:ContractWithCustomerLiabilityRevenueRecognized

us-gaap:DeferredIncomeTaxesAndTaxCredits

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:FinanceLeaseInterestExpense

us-gaap:FinanceLeaseRightOfUseAssetAmortization
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FinitelivedIntangibleAssetsAcquired1

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInReceivables

us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss

us-gaap:InvestmentIncomeInterest

us-gaap:LeaseCost

us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
us-gaap:StatementEquityComponents

us-gaap:OperatingLeaseCost

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments

us-gaap:ProceedsFromStockOptionsExercised
us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:RelatedPartyTransaction
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:RevenueFromRelatedParties

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesAcquisitions

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueAcquisitions
us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap:StatementEquityComponents

atnx:AccruedClinicalExpensesCurrent

atnx:AccruedConstructionCostsCurrent
us-gaap:BalanceSheetLocation, us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType
atnx:AccruedConstructionCostsExpectedToBeFunded
us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType

atnx:AccruedInventoryPurchasesCurrent

atnx:AccruedOperatingExpensesCurrent

atnx:ChargebacksAndOtherDeductionsCurrent
us-gaap:StatementBusinessSegments
us-gaap:RelatedPartyTransactionsByRelatedParty
atnx:CommonStockSharesHeldByRelatedParties

atnx:CurrentPortionOfFinanceAndCapitalLeaseObligation

atnx:DebtCurrentAndNonCurrent
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
atnx:IndefiniteLivedIntangibleAssetsExcludingGoodwillNetCarryingAmount

atnx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
us-gaap:TypeOfArrangement
atnx:LineOfCreditFacilityRemainingBorrowingCapacityOfContingentMilestoneBased

atnx:LongTermDebtAndFinanceLeaseObligationsNonCurrent

atnx:LongTermPortionOfFinanceAndCapitalLeaseLbligation
us-gaap:StatementScenario, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
atnx:PercentageOfInternalRateOfReturnOfProductPayment
us-gaap:StatementBusinessSegments
atnx:RevenueToBeRecognizedUponSatisfactionOfPerformanceObligation

us-gaap:AccountsReceivableGrossCurrent
us-gaap:StatementBusinessSegments

us-gaap:AccruedExchangeFeeRebateCurrent

us-gaap:AccruedRoyaltiesCurrent

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
us-gaap:MajorCustomers
us-gaap:MajorCustomers, us-gaap:Range
us-gaap:StatementBusinessSegments

us-gaap:AssetsFairValueDisclosure
us-gaap:CashAndCashEquivalents, us-gaap:FairValueByAssetClass
us-gaap:CashAndCashEquivalents, us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByAssetClass, us-gaap:CashAndCashEquivalents
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType
us-gaap:FairValueByAssetClass, us-gaap:InvestmentType
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByAssetClass, us-gaap:CashAndCashEquivalents
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByAssetClass, us-gaap:InvestmentType

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType
us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
us-gaap:StatementEquityComponents, us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiability
us-gaap:DeferredRevenueArrangementType, us-gaap:StatementBusinessSegments
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:DebtInstrumentFaceAmount
us-gaap:DebtInstrument
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet

us-gaap:DeferredRevenueCurrent
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:DueToRelatedPartiesNoncurrent
us-gaap:StatementScenario, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:FinanceLeaseLiability

us-gaap:FinanceLeaseLiabilityCurrent

us-gaap:FinanceLeaseLiabilityNoncurrent

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FiniteLivedIntangibleAssetsGross

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
us-gaap:LineOfCreditFacility
us-gaap:LineOfCredit
us-gaap:DebtInstrument, us-gaap:TypeOfArrangement
us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
us-gaap:LineOfCreditFacility
us-gaap:TypeOfArrangement
us-gaap:LineOfCreditFacility, us-gaap:StatementGeographical
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
us-gaap:StatementGeographical, us-gaap:LineOfCreditFacility
us-gaap:TypeOfArrangement
us-gaap:DebtInstrument, us-gaap:TypeOfArrangement
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
us-gaap:TypeOfArrangement

us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
us-gaap:TypeOfArrangement
us-gaap:LongTermDebtPercentageBearingFixedInterestRate

us-gaap:RestrictedCashCurrent
us-gaap:DebtInstrument

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:TreasuryStockShares

Tables

  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:CommonStockValue ███▇▇▄▄▄▃▃▁▁▁0.0830.0830.0830.0790.0790.0690.0690.0680.0650.0650.060.060.059NA0.042NANANA
 us-gaap:SharesOutstanding us-gaap:StatementEquityComponents us-gaap:CommonStock███▇▇▆▆▆▅▅▄▄▄▁▁▁▁83.36245483.29826383.23106379.14230578.93714568.71861868.66898668.56167865.2936664.94884959.89436259.66818458.73652942.35950642.34270641.78470641.784706NA
us-gaap:CommonStockSharesIssued ███▇▇▄▄▄▃▃▁▁▁83.36245483.29826383.23106379.14230578.93714568.71861868.66898668.56167865.2936664.94884959.89436259.66818458.736529NA42.342706NANANA
us-gaap:CommonStockSharesOutstanding ███▇▇▄▄▄▃▃▁▁▁81.68953481.62534381.55814377.46938577.26422567.04569866.99606666.88875863.6207463.27592958.22144257.99526457.063609NA40.685786NANANA
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted █▁81.56444181.539548NA77.29755573.11439267.011432NA66.39909163.31021961.655294NA57.13488943.74109640.693039NA40.26155139.775112NA
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount █▁11.77939911.452475NA11.68426711.44787711.219839NA111.12433511.260610.17102NA11.00149410.4157410.253821NA12.77548612.190387NA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▇█▆▃▄▄▄▃▂▆▃▃▁▁▁▁▁▁40.17246.93534.36119.36422.19725.30721.27118.42811.56537.83614.87313.9944.5954.5815.1135.6165.1934.629
us-gaap:Revenues ▇█▆▃▄▄▄▃▂▆▃▃▁▁▁▁▁▁40.17246.93534.36119.36422.19725.30721.27118.42811.56537.83614.87313.9944.5954.5815.1135.6165.1934.629
us-gaap:CostOfGoodsAndServicesSold █▅▄▄▄▅▄▃▃▃▃▂▁▁33.00619.57215.70417.07116.94219.90214.27111.9659.44311.32610.0648.0824.1372.839NANANANA
us-gaap:GrossProfit 7.166NANANA5.255NANANANANANANANANANANANANA
us-gaap:OperatingExpenses 39.501NANANA35.676NANANANANANANANANANANANANA
us-gaap:CostsAndExpenses NA62.51255.63652.94252.61859.56546.71774.66248.83245.70943.22930.3935.36639.04642.76930.25818.04615.225
us-gaap:ResearchAndDevelopmentExpense ▃▃▃▃▃▄▃█▄▃▃▂▃▄▄▃▁▁22.01517.19221.82319.58818.50724.47520.82851.20426.57221.30320.84811.94417.59726.40827.18118.0528.6456.746
us-gaap:SellingGeneralAndAdministrativeExpense ▅█▆▅▅▅▃▃▄▄▄▃▄▃▃▂▁▁17.48625.74818.10916.28317.16915.18811.61811.49312.81713.0812.31710.36413.6329.79910.2626.794.5674.337
us-gaap:OperatingIncomeLoss ▄▇▆▄▅▄▅▁▄█▅▇▅▄▄▆▇█-32.335-15.577-21.275-33.578-30.421-34.258-25.446-56.234-37.267-7.873-28.356-16.396-30.771-34.465-37.656-24.642-12.853-10.596
us-gaap:InterestExpense ▁▄▅▆▇▇█▅1.5651.6731.71.7451.7541.7551.8041.712NANA-0.0980.3533.281NA1.8830.0050.049NA
us-gaap:InterestPaidNet ▆▅▁█▆▃█1.6911.390.511.9441.490.9812.025NANA0.013NANANANANANANANA
us-gaap:GainsLossesOnExtinguishmentOfDebt -7.23NANANANANANANANANANANANANANANANANA
 us-gaap:GainsLossesOnExtinguishmentOfDebt us-gaap:LongtermDebtType atnx:SeniorSecuredLoanNANANANANANANANANANANANANANANANANANA
us-gaap:AllocatedShareBasedCompensationExpense ▂▂▂▁▂▁▂▂▃▂▂▂▆▁█▃▂3.0532.3312.5822.233.2971.7782.3522.4163.5432.7012.8812.8896.6762.1459.3424.1253.133NA
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest ▃▇▆▄▅▄▅▁▄█▅▆▄▃▃▆▇-40.945-16.837-22.502-34.673-31.7-35.73-26.776-57.292-36.899-7.646-28.258-23.297-38.639-41.117-40.072-24.647-12.902NA
us-gaap:IncomeTaxExpenseBenefit ▂█▂▂▃▃▃▂▂▁▂▂▂▂▂▂▁0.1062.881-0.0910.1140.4050.50.386-0.030.051-0.3070.1370.0110.029-0.0920.0290.009-0.403NA
us-gaap:ProfitLoss ▃▆▆▄▅▄▅▁▄█▅▆▄▃▃▆▇█-41.051-19.718-22.411-34.787-32.105-36.23-27.162-57.262-36.95-7.339-28.395-23.308-38.668-41.025-40.101-24.656-12.499-10.65
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:NoncontrollingInterest▁█-0.6-0.289NA-0.029-0.074-0.997-0.049-11.09-0.091-0.041-0.112-0.034-0.043-0.037-0.047-0.034NANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:Parent▁█-40.451-19.429NA-34.758-32.031-35.233-27.113-46.17-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622NANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁█-40.451-19.429NA-34.758-32.031-35.233-27.113-46.17-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622NANA
us-gaap:OtherComprehensiveIncomeLossNetOfTax █▁0.074-0.506NA-0.309-0.5291.071-0.036-0.591-0.5660.6830.2660.2460.1440.502-0.666-0.051NANA
us-gaap:NetIncomeLoss ▂▆▅▃▄▃▄▁▃█▄▅▂▂▂▅▇▇-40.451-19.429-21.727-34.758-32.031-35.233-27.113-46.171-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622-12.421-10.618
 us-gaap:NetIncomeLoss us-gaap:BusinessAcquisition,us-gaap:StatementBusinessSegments atnx:CIDALLimited,atnx:OncologyInnovationPlatform▁█-1.1-1.0NANANANANANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:CommercialPlatform█▁0.318-12.485NANA-2.552-6.863NANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:GlobalSupplyChainPlatform█▁-5.745-5.986NANA0.313-0.767NANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:OncologyInnovationPlatform▁█-35.024-0.958NANA-29.792-27.603NANANANANANANANANANANANA
us-gaap:ComprehensiveIncomeNetOfTax ▂▆▅▃▃▃▄▁▃█▄▅▂▂▂▅▇-40.377-19.935-21.939-35.067-32.56-34.162-27.149-46.762-37.425-6.615-28.017-23.028-38.481-40.486-40.72-24.673-12.747NA
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest █████▇█▁██████████-0.6-0.289-0.684-0.029-0.074-0.997-0.049-11.091-0.091-0.041-0.112-0.034-0.043-0.037-0.047-0.034-0.078-0.032
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:Assets ▇▇█▇█▄▄▅▂▃▁▁▂298.052297.787309.932287.595322.273220.307231.095244.467177.288197.533140.413148.758157.814NA105.89NANANA
us-gaap:Liabilities █▆▆▇▇▆▄▄▂▁▂▁▁171.806139.551134.077152.769155.066124.726102.32692.4152.8841.44849.69133.85837.44NA71.221NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▇▇█▇█▄▄▅▂▃▁▁▂298.052297.787309.932287.595322.273220.307231.095244.467177.288197.533140.413148.758157.814NA105.89NANANA
us-gaap:StockholdersEquity ▅▇█▅▇▂▅▆▃▆▁▃▃139.307170.895188.225146.512178.864107.164139.355162.594123.855155.44190.037114.103119.543NA33.807NANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:AssetsCurrent ▇▇▇▆█▄▅▅▃▃▁▁▂216.606217.9230.926213.541249.687150.68170.819187.702119.553140.0983.75893.013102.321NA51.923NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▇▅█▄▆▅▃▃▁▃▃▁▄▂▂▃▂105.90171.983127.67461.48196.73471.00349.79451.10814.06839.21739.28419.26255.1526.03433.12543.53126.14NA
us-gaap:ShortTermInvestments ▂▄▄▄▄▁▅█▆▆▂▅▃10.41441.72133.13942.27343.7180.34157.62990.30966.59367.25911.75349.78130.15NA8.628NANANA
us-gaap:AccountsReceivableNetCurrent ▆█▃▃▂▃▂▁▁▂▂▁▁38.6251.41816.68917.1689.56420.57612.9517.0715.1387.8458.4686.4593.783NA2.777NANANA
us-gaap:InventoryNet ▇█▇▆▆▅▆▅▄▃▃▂▁31.14335.73232.6328.45127.23925.19128.78725.23121.80318.57116.56111.6359.26NA4.24NANANA
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ▄▃▄▇█▆▄▃▂▂▂▁▁19.52817.04620.79438.74446.96833.56921.65813.98311.9517.1987.6925.8763.978NA3.153NANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:AmortizationOfIntangibleAssets ██████▆▆▆▆▆▆▆▆▄▃▁0.50.50.50.50.50.50.40.40.40.40.40.40.40.40.30.20.1NA
us-gaap:PropertyPlantAndEquipmentNet █▇▇▅▄▂▂▂▂▂▂▁▁26.86724.61623.15319.27216.30612.24911.44711.17410.40410.3689.6518.8248.321NA5.81NANANA
us-gaap:Goodwill ███▁▂▃▂▂▃▅▄▃▃38.49638.4838.51337.29337.52837.58937.49537.50137.66537.94637.79537.69137.6NA37.552NANANA
 us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass atnx:CDEInProgressResearchAndDevelopment▁▁▁▁▁▁▃▃▃▃▄▄█0.7230.7230.7280.7150.7180.7281.0261.0261.0251.0261.1061.1061.636NA1.884NANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ▂▃▃▄▆▇█▁▂▃▄▄▅8.0158.5258.5228.9729.76910.36110.8487.2547.7368.2768.5728.9059.242NA8.464NANANA
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass atnx:PolymedCustomerList▁▂▂▃▃▄▄▅▆▆▇▇█0.3020.3650.4290.4920.5560.6190.6550.720.7850.8490.9180.9821.048NA1.179NANANA
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass atnx:PolymedTechnology▁▂▂▃▃▃▅▅▅▆▆▇█2.2952.3682.4152.5182.5412.5872.7132.7822.8192.8472.953.043.129NA3.275NANANA
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass us-gaap:LicensingAgreements▅▆▅▆▇▇█▁▁▂▂▃▃5.165.5435.3745.7516.1276.5036.8752.8143.0353.2573.4773.6983.919NA2.785NANANA
us-gaap:OperatingLeaseRightOfUseAsset ▁▃▅▄▆█7.8468.2668.8188.5178.9839.428NANANANANANANANANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:LiabilitiesCurrent ▅▆▆▇█▅▄▃▃▂▃▁▁66.90976.79671.52889.96895.31567.74751.67642.09647.75136.63245.14329.83727.097NA28.019NANANA
us-gaap:LongTermDebtCurrent ▇▇▇▁███0.6760.6740.6860.070.770.7920.779NANANA0.8350.7980.789NA0.766NANANA
us-gaap:AccountsPayableCurrent ▅▆█▅▅▇▄▄▄▅▅▁▁15.94518.39523.33116.20615.58320.38912.99712.69414.34216.1516.6596.6227.315NA7.174NANANA
us-gaap:AccruedIncomeTaxesCurrent ██▁5.2285.2810.187NANANANANANANANANANANANANANANA
us-gaap:AccruedLiabilitiesCurrent ▅▆▄▇█▄▄▃▃▁▃▂▁47.14454.73944.30769.99475.12442.57137.71828.0626.83313.50726.97821.59417.886NA18.956NANANA
us-gaap:OperatingLeaseLiabilityCurrent ▁▃█2.7132.7913.01NANANANANANANANANANANANANANANA
us-gaap:ContractWithCustomerLiabilityCurrent ▁▁▁██▁▁▁▃0.0970.0750.21820.07120.1550.1310.190.3645.526NA1.202NANANANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
 us-gaap:LongTermDebtNoncurrent us-gaap:LongtermDebtType atnx:SeniorSecuredLoan█▁▁▁▁▁▁88.24746.66446.40846.15145.89545.63845.381NANANANANANANANANANANA
us-gaap:MinorityInterest ▁▁▁▂▂▂▂▂█████-13.061-12.659-12.37-11.686-11.657-11.583-10.586-10.5370.5530.6440.6850.7970.831NA0.862NANANA
us-gaap:OtherLiabilitiesNoncurrent █▄▁2.6072.5852.563NANANA4.847NANANANANANANANANANANA
us-gaap:OperatingLeaseLiabilityNoncurrent ▁▄█6.857.2267.62NANANANANANANANANANANANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:StockholdersEquity ▅▇█▅▇▂▅▆▃▆▁▃▃139.307170.895188.225146.512178.864107.164139.355162.594123.855155.44190.037114.103119.543NA33.807NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▆▇█▆█▅▆▇▆▇▅▆▆▁▂▄▅126.246158.236175.855134.826167.20795.581128.769152.057124.408156.08590.722114.9120.374-3.61734.66969.60890.234NA
us-gaap:CommonStockValue ███▇▇▄▄▄▃▃▁▁▁0.0830.0830.0830.0790.0790.0690.0690.0680.0650.0650.060.060.059NA0.042NANANA
us-gaap:AdditionalPaidInCapitalCommonStock ███▇▇▅▅▄▃▃▁▁▁775.042766.253763.648700.0697.285593.035591.064587.155501.658495.819423.805419.854402.267NA237.581NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▁▂▂▃▃▄▅▅▆▇▇██-627.345-586.894-567.465-545.738-510.98-478.949-443.716-416.603-370.433-333.574-326.276-297.993-274.719NA-195.106NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▁▁▃▄▅▇▃▃▆█▅▄▃-1.067-1.141-0.635-0.423-0.1140.415-0.656-0.62-0.0290.537-0.146-0.412-0.658NA-1.304NANANA
us-gaap:MinorityInterest ▁▁▁▂▂▂▂▂█████-13.061-12.659-12.37-11.686-11.657-11.583-10.586-10.5370.5530.6440.6850.7970.831NA0.862NANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▅▁▅▃█▃▃▂▄▇▆▆-24.523-45.545-23.34-36.347-4.802-32.971-34.072-37.286-25.303-12.726-17.868-14.841NANANANANANA
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▄▅▅▂█▇▃▅▁▇▃28.576-10.4514.911-2.176-47.43452.19832.162-24.5720.247-56.837.004-20.485NANANANANANA
us-gaap:NetCashProvidedByUsedInFinancingActivities ▄▁▅▁█▁▁█▁▆▁▁40.8410.73259.4013.353103.7220.9760.67199.2650.11868.9810.803-0.698NANANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▅▁▅▃█▃▃▂▄▇▆▆-24.523-45.545-23.34-36.347-4.802-32.971-34.072-37.286-25.303-12.726-17.868-14.841NANANANANANA
us-gaap:NetIncomeLoss ▂▆▅▃▄▃▄▁▃█▄▅▂▂▂▅▇▇-40.451-19.429-21.727-34.758-32.031-35.233-27.113-46.171-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622-12.421-10.618
 us-gaap:NetIncomeLoss us-gaap:BusinessAcquisition,us-gaap:StatementBusinessSegments atnx:CIDALLimited,atnx:OncologyInnovationPlatform▁█-1.1-1.0NANANANANANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:CommercialPlatform█▁0.318-12.485NANA-2.552-6.863NANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:GlobalSupplyChainPlatform█▁-5.745-5.986NANA0.313-0.767NANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments atnx:OncologyInnovationPlatform▁█-35.024-0.958NANA-29.792-27.603NANANANANANANANANANANANA
us-gaap:ProfitLoss ▃▆▆▄▅▄▅▁▄█▅▆▄▃▃▆▇█-41.051-19.718-22.411-34.787-32.105-36.23-27.162-57.262-36.95-7.339-28.395-23.308-38.668-41.025-40.101-24.656-12.499-10.65
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:NoncontrollingInterest▁█-0.6-0.289NA-0.029-0.074-0.997-0.049-11.09-0.091-0.041-0.112-0.034-0.043-0.037-0.047-0.034NANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:Parent▁█-40.451-19.429NA-34.758-32.031-35.233-27.113-46.17-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622NANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁█-40.451-19.429NA-34.758-32.031-35.233-27.113-46.17-36.859-7.298-28.283-23.274-38.625-40.988-40.054-24.622NANA
us-gaap:DepreciationDepletionAndAmortization ██▇▇▇▆▆▆▇▆█▆▆▅▄▃▁1.0351.0861.0091.0010.9280.8790.8450.9090.9470.8681.0880.9210.8480.8160.6960.5780.335NA
us-gaap:IncreaseDecreaseInInventories ▁▇▇▅▆▂▇▇▇▆█▆▆▆▄▄-4.5883.1014.181.2122.048-3.5963.5563.4283.2322.014.9262.3752.4252.5950.024-0.121NANA
us-gaap:ShareBasedCompensation ▂▁▂▁▂▁▂▂▃▂▂▂▆▁█▃3.0532.2612.6622.1483.2971.7782.3522.4153.5432.7012.8812.896.6752.1459.3424.126NANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▄▅▅▂█▇▃▅▁▇▃28.576-10.4514.911-2.176-47.43452.19832.162-24.5720.247-56.837.004-20.485NANANANANANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▅▃█▆▆▂▂▂▁▂▂▂▃▃▁▁2.831.7365.0593.6223.9730.9180.820.8660.4581.1771.0560.9421.8881.5540.3670.614NANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▄▁▅▁█▁▁█▁▆▁▁40.8410.73259.4013.353103.7220.9760.67199.2650.11868.9810.803-0.698NANANANANANA
us-gaap:ProceedsFromIssuanceOfLongTermDebt █▁▁▁▁▁▁94.7290.4350.02.8152.9060.7430.0NANANANANANANANANANANA
  2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31

None

us-gaap:CommonStockValue

us-gaap:CommonStockValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value83000.083000.083000.079000.079000.069000.069000.068000.065000.065000.060000.060000.059000.042000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:SharesOutstanding us-gaap:StatementEquityComponents

us-gaap:SharesOutstanding

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value83838379786868686564595958424241414023
Percentage of SharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.67292-1.65692-0.687528-0.668528-0.422328-0.422328
Percentage of SharesOutstanding-2.0-2.0-2.0-2.1-2.1-2.4-2.4-2.4-2.6-2.6-2.8-2.8-2.8-3.9-3.9-1.6-1.6-1.0-1.8

None

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesIssued


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value8383837978686868656459595842
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:CommonStockSharesOutstanding

us-gaap:CommonStockSharesOutstanding


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value8181817777676666636358575740
Percentage of CommonStockSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-30
Value81817773676663615743404039
Percentage of WeightedAverageNumberOfShareOutstandingBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-30
Value111111111111111101110101212
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

atnx:UnvestedRestrictedCommonShares


None
Period End2020-06-302020-03-312019-09-302018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value0.0790.1050.0494570.0048910.2050.240.2650.5966510.661982
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount0.70.90.40.01.82.42.45.76.5

us-gaap:StockCompensationPlan


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-30
Value1111111111111119.93102109.8190899.5918391111
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount99.399.199.6100.0100.0100.098.297.697.694.393.588.891.4

None

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value4046341922252118113714134.5954.5815.1135.6165.1934.629
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems

us-gaap:IntersegmentElimination


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value-1.029-0.708-1.184-0.726-0.97-0.851-1.676-1.096-1.388-1.216-2.294-2.19-2.004-2.525-2.426-2.274-1.46
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.6-1.5-3.4-3.7-4.4-3.4-7.9-5.9-12.0-3.2-15.4-15.6-43.6-55.1-47.4-40.5-28.1
Percentage of Revenues-2.6-1.5-3.4-3.7-4.4-3.4-7.9-5.9-12.0-3.2-15.4-15.6-43.6-55.1-47.4-40.5-28.1
Percentage of Revenues us-gaap:IntersegmentElimination0.00.00.00.00.00.00.00.00.0100.00.0100.0100.0100.00.0100.0100.0

us-gaap:OperatingSegments


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value4147352023262219123917166.5997.1067.5397.896.653
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax102.6101.5103.4103.7104.4103.4107.9105.9112.0103.2115.4115.6143.6155.1147.4140.5128.1
Percentage of Revenues102.6101.5103.4103.7104.4103.4107.9105.9112.0103.2115.4115.6143.6155.1147.4140.5128.1
Percentage of Revenues us-gaap:OperatingSegments0.00.00.00.00.00.00.00.00.0100.00.0100.0100.0100.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, atnx:CommercialPlatform


None
Period End2020-06-302019-06-302017-06-302016-06-30
Value36111.820.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax90.152.239.60.0
Percentage of Revenues90.152.239.60.0
Percentage of Revenues us-gaap:OperatingSegments atnx:CommercialPlatform0.00.0100.00.0

us-gaap:OperatingSegments, atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302019-06-302017-06-302016-06-30
Value4.982114.5096.249
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.451.498.1120.3
Percentage of Revenues12.451.498.1120.3
Percentage of Revenues us-gaap:OperatingSegments atnx:GlobalSupplyChainPlatform0.00.0100.0100.0

us-gaap:OperatingSegments, atnx:OncologyInnovationPlatform


None
Period End2020-06-302019-06-302017-06-302016-06-30
Value0.0050.1640.270.404
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.75.97.8
Percentage of Revenues0.00.75.97.8
Percentage of Revenues us-gaap:OperatingSegments atnx:OncologyInnovationPlatform0.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

atnx:ActivePharmaceuticalIngredientSales


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value1.2291.0220.4253.6473.834.8318.4143.693.2062.6424.9825.3452.0243.03.5914.0513.726
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.12.21.218.817.319.139.620.027.77.033.538.244.065.570.272.171.8
Percentage of Revenues3.12.21.218.817.319.139.620.027.77.033.538.244.065.570.272.171.8
Percentage of Revenues atnx:ActivePharmaceuticalIngredientSales0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

atnx:CommercialProductSales


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value381713151820108.287.6769.1378.1017.5051.9130.1280.1780.0180.031
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax96.837.339.880.081.879.349.644.966.424.154.553.641.62.83.50.30.6
Percentage of Revenues96.837.339.880.081.879.349.644.966.424.154.553.641.62.83.50.30.6
Percentage of Revenues atnx:CommercialProductSales0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

atnx:ContractManufacturingRevenue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value0.0570.0230.0090.0930.0380.2510.0460.0170.1540.2410.4260.250.2470.4370.2680.5170.544
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.00.00.50.21.00.20.11.30.62.91.85.49.55.29.210.5
Percentage of Revenues0.10.00.00.50.21.00.20.11.30.62.91.85.49.55.29.210.5
Percentage of Revenues atnx:ContractManufacturingRevenue0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

atnx:LicenseAndOtherRevenue


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value0.005280.1640.144
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.060.50.70.6
Percentage of Revenues0.060.50.70.6
Percentage of Revenues atnx:LicenseAndOtherRevenue0.00.00.00.0

us-gaap:License


None
Period End2020-06-302020-03-31
Value0.028
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.060.5
Percentage of Revenues0.060.5
Percentage of Revenues us-gaap:License0.00.0

us-gaap:Product


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value4018141922251913111214134.4163.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.039.541.099.399.399.489.472.299.233.395.097.696.185.1
Percentage of Revenues100.039.541.099.399.399.489.472.299.233.395.097.696.185.1
Percentage of Revenues us-gaap:Product0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ProductAndServiceOther


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value0.0050.0070.1640.144
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.70.6
Percentage of Revenues0.00.00.70.6
Percentage of Revenues us-gaap:ProductAndServiceOther0.00.00.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Range, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:StatementBusinessSegments, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

srt:Maximum, atnx:SagardHealthcareRoyaltyPartnersLP, atnx:OncologyInnovationPlatform, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value500
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0
Percentage of Revenues0.0
Percentage of Revenues srt:Maximum atnx:SagardHealthcareRoyaltyPartnersLP atnx:OncologyInnovationPlatform us-gaap:SubsequentEvent atnx:RevenueInterestFinancingAgreement0.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:ConsolidationItems

atnx:CommercialPlatform, us-gaap:OperatingSegments


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value151211147.3156.9978.6947.3781.820.0770.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax33.162.052.258.039.760.523.052.739.61.70.0
Percentage of Revenues33.162.052.258.039.760.523.052.739.61.70.0
Percentage of Revenues atnx:CommercialPlatform us-gaap:OperatingSegments0.00.00.00.00.00.0100.0100.00.0100.00.0

atnx:GlobalSupplyChainPlatform, us-gaap:OperatingSegments


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value3.7147.96911117.0925.7725.1278.6014.5096.2967.767
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.941.251.444.838.549.913.661.598.1137.4138.3
Percentage of Revenues7.941.251.444.838.549.913.661.598.1137.4138.3
Percentage of Revenues atnx:GlobalSupplyChainPlatform us-gaap:OperatingSegments0.00.00.00.00.00.0100.0100.00.0100.0100.0

atnx:OncologyInnovationPlatform, us-gaap:OperatingSegments


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value280.1150.1630.1445.1170.184250.2050.270.7330.123
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax60.50.60.70.627.81.666.71.55.916.02.2
Percentage of Revenues60.50.60.70.627.81.666.71.55.916.02.2
Percentage of Revenues atnx:OncologyInnovationPlatform us-gaap:OperatingSegments0.00.00.00.00.00.0100.0100.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService

atnx:CommercialPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value361211147.3156.9978.6940.077
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax90.162.052.258.039.760.523.01.7
Percentage of Revenues90.162.052.258.039.760.523.01.7
Percentage of Revenues atnx:CommercialPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

atnx:GlobalSupplyChainPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value3.9537.24310105.9964.3843.9113.771
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.837.447.041.432.537.910.382.3
Percentage of Revenues9.837.447.041.432.537.910.382.3
Percentage of Revenues atnx:GlobalSupplyChainPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

atnx:OncologyInnovationPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value0.0050.1150.1630.1445.1170.184250.733
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.60.70.627.81.666.716.0
Percentage of Revenues0.00.60.70.627.81.666.716.0
Percentage of Revenues atnx:OncologyInnovationPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical

atnx:OtherForeignCountriesIncludingAustria


None
Period End2020-06-30
Value0.053
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.1
Percentage of Revenues0.1
Percentage of Revenues atnx:OtherForeignCountriesIncludingAustria0.0

country:AT


None
Period End2020-06-302019-06-302019-03-31
Value0.0331.7732.173
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.18.08.6
Percentage of Revenues0.18.08.6
Percentage of Revenues country:AT0.00.00.0

country:CN


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value0.125280.2680.5630.8890.3862.4990.3060.9620.6481.0371.0380.417
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.360.70.82.94.01.511.71.78.31.77.07.49.1
Percentage of Revenues0.360.70.82.94.01.511.71.78.31.77.07.49.1
Percentage of Revenues country:CN0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

country:GB


None
Period End2020-06-302019-12-312019-09-302019-06-302019-03-31
Value120.00.00.01.023
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.20.00.00.04.0
Percentage of Revenues32.20.00.00.04.0
Percentage of Revenues country:GB0.00.00.00.0100.0

country:US


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value261713151820109.5597.9449.9018.8788.1142.227
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax64.737.339.880.781.880.449.451.968.726.259.758.048.5
Percentage of Revenues64.737.339.880.781.880.449.451.968.726.259.758.048.5
Percentage of Revenues country:US0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

currency:KRW


None
Period End2020-06-302019-09-30
Value1.060.513
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.6
Percentage of Revenues2.62.6
Percentage of Revenues currency:KRW0.0100.0

us-gaap:NonUs


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value0.020.91.5340.1060.770.6132.051.0770.5460.082-0.0260.8630.445
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.01.94.50.53.52.49.65.84.70.2-0.26.29.7
Percentage of Revenues0.01.94.50.53.52.49.65.84.70.2-0.26.29.7
Percentage of Revenues us-gaap:NonUs0.00.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService

atnx:OtherForeignCountriesIncludingAustria, atnx:GlobalSupplyChainPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-30
Value0.053
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.1
Percentage of Revenues0.1
Percentage of Revenues atnx:OtherForeignCountriesIncludingAustria atnx:GlobalSupplyChainPlatform us-gaap:TransferredAtPointInTime0.0

country:CN, atnx:GlobalSupplyChainPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value0.120.4480.7260.2420.1890.7780.4170.079
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.32.33.31.01.06.71.11.7
Percentage of Revenues0.32.33.31.01.06.71.11.7
Percentage of Revenues country:CN atnx:GlobalSupplyChainPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

country:CN, atnx:OncologyInnovationPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value0.0050.1150.1630.1440.1170.1840.2310.233
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.60.70.60.61.60.65.1
Percentage of Revenues0.00.60.70.60.61.60.65.1
Percentage of Revenues country:CN atnx:OncologyInnovationPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

country:GB, atnx:CommercialPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-30
Value12
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.2
Percentage of Revenues32.2
Percentage of Revenues country:GB atnx:CommercialPlatform us-gaap:TransferredAtPointInTime0.0

country:US, atnx:CommercialPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value231211147.3156.9978.6940.077
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax58.062.052.258.039.760.523.01.7
Percentage of Revenues58.062.052.258.039.760.523.01.7
Percentage of Revenues country:US atnx:CommercialPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

country:US, atnx:GlobalSupplyChainPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-03-31
Value2.723.6186.5635.662.2440.9471.2080.636
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.818.729.622.412.28.23.213.9
Percentage of Revenues6.818.729.622.412.28.23.213.9
Percentage of Revenues country:US atnx:GlobalSupplyChainPlatform us-gaap:TransferredAtPointInTime0.00.00.00.00.00.0100.0100.0

currency:KRW, atnx:GlobalSupplyChainPlatform, us-gaap:TransferredAtPointInTime


None
Period End2020-06-302019-09-30
Value1.060.513
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.6
Percentage of Revenues2.62.6
Percentage of Revenues currency:KRW atnx:GlobalSupplyChainPlatform us-gaap:TransferredAtPointInTime0.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments

country:CN, us-gaap:TransferredAtPointInTime, atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value0.2050.1890.7780.8330.147
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.41.06.76.03.2
Percentage of Revenues0.41.06.76.03.2
Percentage of Revenues country:CN us-gaap:TransferredAtPointInTime atnx:GlobalSupplyChainPlatform0.00.00.00.00.0

country:CN, us-gaap:TransferredAtPointInTime, atnx:OncologyInnovationPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value280.1170.1840.2050.27
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax60.30.61.61.55.9
Percentage of Revenues60.30.61.61.55.9
Percentage of Revenues country:CN us-gaap:TransferredAtPointInTime atnx:OncologyInnovationPlatform0.00.00.00.00.0

country:US, us-gaap:TransferredAtPointInTime, atnx:CommercialPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value157.3156.9977.3781.82
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax33.139.760.552.739.6
Percentage of Revenues33.139.760.552.739.6
Percentage of Revenues country:US us-gaap:TransferredAtPointInTime atnx:CommercialPlatform0.00.00.00.00.0

country:US, us-gaap:TransferredAtPointInTime, atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value1.982.2440.9470.7360.407
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.212.28.25.38.9
Percentage of Revenues4.212.28.25.38.9
Percentage of Revenues country:US us-gaap:TransferredAtPointInTime atnx:GlobalSupplyChainPlatform0.00.00.00.00.0

us-gaap:NonUs, us-gaap:TransferredAtPointInTime, atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value0.8211.0770.5460.8630.445
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.75.84.76.29.7
Percentage of Revenues1.75.84.76.29.7
Percentage of Revenues us-gaap:NonUs us-gaap:TransferredAtPointInTime atnx:GlobalSupplyChainPlatform0.00.00.00.00.0

us-gaap:NonUs, us-gaap:TransferredAtPointInTime, atnx:OncologyInnovationPlatform


None
Period End2020-03-31
Value0.079
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.2
Percentage of Revenues0.2
Percentage of Revenues us-gaap:NonUs us-gaap:TransferredAtPointInTime atnx:OncologyInnovationPlatform0.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments

us-gaap:TransferredAtPointInTime, atnx:CommercialPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value157.3156.9977.3781.82
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax33.139.760.552.739.6
Percentage of Revenues33.139.760.552.739.6
Percentage of Revenues us-gaap:TransferredAtPointInTime atnx:CommercialPlatform0.00.00.00.00.0

us-gaap:TransferredAtPointInTime, atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value3.0065.9964.3846.4112.505
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.432.537.945.854.5
Percentage of Revenues6.432.537.945.854.5
Percentage of Revenues us-gaap:TransferredAtPointInTime atnx:GlobalSupplyChainPlatform0.00.00.00.00.0

us-gaap:TransferredAtPointInTime, atnx:OncologyInnovationPlatform


None
Period End2020-03-312018-09-302018-06-302017-09-302017-06-30
Value285.1170.1840.2050.27
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax60.527.81.61.55.9
Percentage of Revenues60.527.81.61.55.9
Percentage of Revenues us-gaap:TransferredAtPointInTime atnx:OncologyInnovationPlatform0.00.00.00.00.0

None

us-gaap:Revenues

us-gaap:Revenues


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value4046341922252118113714134.5954.5815.1135.6165.1934.629
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:CostOfGoodsAndServicesSold

us-gaap:CostOfGoodsAndServicesSold


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value33191517161914119.44311108.0824.1372.839
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues82.241.745.788.276.378.667.164.981.729.967.757.890.062.0

None

us-gaap:GrossProfit

us-gaap:GrossProfit


None
Period End2020-06-302019-06-30
Value7.1665.255
Percentage of GrossProfit100.0100.0
Percentage of Revenues17.823.7

None

us-gaap:OperatingExpenses

us-gaap:OperatingExpenses


None
Period End2020-06-302019-06-30
Value3935
Percentage of OperatingExpenses100.0100.0
Percentage of Revenues98.3160.7

None

us-gaap:CostsAndExpenses

us-gaap:CostsAndExpenses


None
Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value6255525259467448454330353942301815
Percentage of CostsAndExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues133.2161.9273.4237.1235.4219.6405.2422.2120.8290.7217.2769.7852.3836.5538.8347.5328.9

None

us-gaap:ResearchAndDevelopmentExpense

us-gaap:ResearchAndDevelopmentExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value221721191824205126212011172627188.6456.746
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues54.836.663.5101.283.496.797.9277.9229.856.3140.285.4383.0576.5531.6321.4166.5145.7

None

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:SellingGeneralAndAdministrativeExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value172518161715111112131210139.799106.794.5674.337
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues43.554.952.784.177.360.054.662.4110.834.682.874.1296.7213.9200.7120.987.993.7

None

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-32335000.0-15577000.0-21275000.0-33578000.0-30421000.0-34258000.0-25446000.0-56234000.0-37267000.0-7873000.0-28356000.0-16396000.0-30771000.0-34465000.0-37656000.0-24642000.0-12853000.0-10596000.0
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-80.5-33.2-61.9-173.4-137.1-135.4-119.6-305.2-322.2-20.8-190.7-117.2-669.7-752.3-736.5-438.8-247.5-228.9

None

us-gaap:InterestExpense

us-gaap:InterestExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302016-12-312016-09-302016-06-30
Value1565000.01673000.01700000.01745000.01754000.01755000.01804000.01712000.0-98000.0353000.03281000.01883000.05000.049000.0
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues3.93.64.99.07.96.98.59.3-0.72.571.436.80.10.9

None

us-gaap:InterestPaidNet

us-gaap:InterestPaidNet


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-03-31
Value1691000.01390000.0510000.01944000.01490000.0981000.02025000.013000.0
Percentage of InterestPaidNet100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues4.23.01.510.06.73.99.50.0

None

us-gaap:GainsLossesOnExtinguishmentOfDebt

us-gaap:GainsLossesOnExtinguishmentOfDebt


None
Period End2020-06-30
Value-7230000.0
Percentage of GainsLossesOnExtinguishmentOfDebt100.0
Percentage of Revenues-18.0

us-gaap:GainsLossesOnExtinguishmentOfDebt us-gaap:LongtermDebtType

atnx:SeniorSecuredLoan


None
Period End2020-06-19
Value-7200000.0
Percentage of GainsLossesOnExtinguishmentOfDebt0.0
Percentage of Revenues0.0
Percentage of Revenues atnx:SeniorSecuredLoan0.0

None

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value3.0532.3312.5822.233.2971.7782.3522.4163.5432.7012.8812.8896.6762.1459.3424.1253.133
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues7.65.07.511.514.97.011.113.130.67.119.420.6145.346.8182.773.560.3

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:AwardType

atnx:EmployeeStockPurchasePlan


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value0.1390.070.0770.0820.0830.0850.1230.094
Percentage of AllocatedShareBasedCompensationExpense4.63.03.03.72.54.85.23.9
Percentage of Revenues0.30.10.20.40.40.30.60.5
Percentage of Revenues atnx:EmployeeStockPurchasePlan0.00.00.00.00.00.00.00.0

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value2.51.8642.0792.0082.1081.6932.2282.3163.0812.1612.3412.3491.7361.6054.7812.3192.013
Percentage of AllocatedShareBasedCompensationExpense81.980.080.590.063.995.294.795.987.080.081.381.326.074.851.256.264.3
Percentage of Revenues6.24.06.110.49.56.710.512.626.65.715.716.837.835.093.541.338.8
Percentage of Revenues us-gaap:EmployeeStockOption0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RestrictedStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value0.40.3970.4260.140.00.0010.0060.4620.540.540.540.540.544.5611.8061.12
Percentage of AllocatedShareBasedCompensationExpense13.117.016.56.30.00.00.213.020.018.718.78.125.248.843.835.7
Percentage of Revenues1.00.81.20.70.00.00.04.01.43.63.911.811.889.232.221.6
Percentage of Revenues us-gaap:RestrictedStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

us-gaap:CostOfSales


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value0.0550.0540.0590.0620.0640.0640.0640.0640.0560.0440.0410.0480.0260.022
Percentage of AllocatedShareBasedCompensationExpense1.82.32.32.81.93.62.72.61.61.61.41.70.41.0
Percentage of Revenues0.10.10.20.30.30.30.30.30.50.10.30.30.60.5
Percentage of Revenues us-gaap:CostOfSales0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value1.0120.9461.00.7460.9140.5910.7060.6880.7140.5130.5550.5670.4470.4623.5891.821.61
Percentage of AllocatedShareBasedCompensationExpense33.140.638.733.527.733.230.028.520.219.019.319.66.721.538.444.151.4
Percentage of Revenues2.52.02.93.94.12.33.33.76.21.43.74.19.710.170.232.431.0
Percentage of Revenues us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:SellingGeneralAndAdministrativeExpenses


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value1.9861.3311.5231.4222.3191.1231.5821.6642.7732.1442.2852.2746.2031.6615.7532.3051.523
Percentage of AllocatedShareBasedCompensationExpense65.157.159.063.870.363.267.368.978.379.479.378.792.977.461.655.948.6
Percentage of Revenues4.92.84.47.310.44.47.49.024.05.715.416.2135.036.3112.541.029.3
Percentage of Revenues us-gaap:SellingGeneralAndAdministrativeExpenses0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:PlanName, us-gaap:SubsidiarySaleOfStock

atnx:TwoThousandSeventeenOmnibusIncentivePlanAndTwoThousandSeventeenEmployeeStockPurchasePlan, us-gaap:EmployeeStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-03-312017-12-312017-09-30
Value0.10.10.10.10.10.10.10.10.00.00.0
Percentage of AllocatedShareBasedCompensationExpense3.34.33.94.53.05.64.34.10.00.00.0
Percentage of Revenues0.20.20.30.50.50.40.50.50.00.00.0
Percentage of Revenues atnx:TwoThousandSeventeenOmnibusIncentivePlanAndTwoThousandSeventeenEmployeeStockPurchasePlan us-gaap:EmployeeStock0.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value-40945000.0-16837000.0-22502000.0-34673000.0-31700000.0-35730000.0-26776000.0-57292000.0-36899000.0-7646000.0-28258000.0-23297000.0-38639000.0-41117000.0-40072000.0-24647000.0-12902000.0
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-101.9-35.9-65.5-179.1-142.8-141.2-125.9-310.9-319.1-20.2-190.0-166.5-840.9-897.6-783.7-438.9-248.4

None

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value106000.02881000.0-91000.0114000.0405000.0500000.0386000.0-30000.051000.0-307000.0137000.011000.029000.0-92000.029000.09000.0-403000.0
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.36.1-0.30.61.82.01.8-0.20.4-0.80.90.10.6-2.00.60.2-7.8

None

us-gaap:ProfitLoss

us-gaap:ProfitLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-41051000.0-19718000.0-22411000.0-34787000.0-32105000.0-36230000.0-27162000.0-57262000.0-36950000.0-7339000.0-28395000.0-23308000.0-38668000.0-41025000.0-40101000.0-24656000.0-12499000.0-10650000.0
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-102.2-42.0-65.2-179.6-144.6-143.2-127.7-310.7-319.5-19.4-190.9-166.6-841.5-895.5-784.3-439.0-240.7-230.1

us-gaap:ProfitLoss us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-600000.0-289000.0-29000.0-74000.0-997000.0-49000.0-11090000.0-91000.0-41000.0-112000.0-34000.0-43000.0-37000.0-47000.0-34000.0
Percentage of ProfitLoss1.51.50.10.22.80.219.40.20.60.40.10.10.10.10.1
Percentage of Revenues-1.5-0.6-0.1-0.3-3.9-0.2-60.2-0.8-0.1-0.8-0.2-0.9-0.8-0.9-0.6
Percentage of Revenues us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-40451000.0-19429000.0-34758000.0-32031000.0-35233000.0-27113000.0-46170000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0
Percentage of ProfitLoss98.598.599.999.897.299.880.699.899.499.699.999.999.999.999.9
Percentage of Revenues-100.7-41.4-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4
Percentage of Revenues us-gaap:Parent0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-40451000.0-19429000.0-34758000.0-32031000.0-35233000.0-27113000.0-46170000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0
Percentage of ProfitLoss98.598.599.999.897.299.880.699.899.499.699.999.999.999.999.9
Percentage of Revenues-100.7-41.4-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4
Percentage of Revenues us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value74000.0-506000.0-309000.0-529000.01071000.0-36000.0-591000.0-566000.0683000.0266000.0246000.0144000.0502000.0-666000.0-51000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.2-1.1-1.6-2.44.2-0.2-3.2-4.91.81.81.83.111.0-13.0-0.9

us-gaap:OtherComprehensiveIncomeLossNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value74000.0-506000.0-309000.0-529000.01071000.0-36000.0-591000.0-566000.0683000.0266000.0246000.0144000.0502000.0-666000.0-51000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.2-1.1-1.6-2.44.2-0.2-3.2-4.91.81.81.83.111.0-13.0-0.9
Percentage of Revenues us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value74000.0-506000.0-309000.0-529000.01071000.0-36000.0-591000.0-566000.0683000.0266000.0246000.0144000.0502000.0-666000.0-51000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.2-1.1-1.6-2.44.2-0.2-3.2-4.91.81.81.83.111.0-13.0-0.9
Percentage of Revenues us-gaap:Parent0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-40451000.0-19429000.0-21727000.0-34758000.0-32031000.0-35233000.0-27113000.0-46171000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0-12421000.0-10618000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-100.7-41.4-63.2-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4-239.2-229.4

us-gaap:NetIncomeLoss us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments

atnx:CIDALLimited, atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-31
Value-1100000.0-1000000.0
Percentage of NetIncomeLoss2.75.1
Percentage of Revenues-2.7-2.1
Percentage of Revenues atnx:CIDALLimited atnx:OncologyInnovationPlatform0.00.0

us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value318000.0-12485000.0-2552000.0-6863000.0
Percentage of NetIncomeLoss-0.864.38.019.5
Percentage of Revenues0.8-26.6-11.5-27.1
Percentage of Revenues atnx:CommercialPlatform0.00.00.00.0

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-5745000.0-5986000.0313000.0-767000.0
Percentage of NetIncomeLoss14.230.8-1.02.2
Percentage of Revenues-14.3-12.81.4-3.0
Percentage of Revenues atnx:GlobalSupplyChainPlatform0.00.00.00.0

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-35024000.0-958000.0-29792000.0-27603000.0
Percentage of NetIncomeLoss86.64.993.078.3
Percentage of Revenues-87.2-2.0-134.2-109.1
Percentage of Revenues atnx:OncologyInnovationPlatform0.00.00.00.0

None

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value-40377000.0-19935000.0-21939000.0-35067000.0-32560000.0-34162000.0-27149000.0-46762000.0-37425000.0-6615000.0-28017000.0-23028000.0-38481000.0-40486000.0-40720000.0-24673000.0-12747000.0
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-100.5-42.5-63.8-181.1-146.7-135.0-127.6-253.8-323.6-17.5-188.4-164.6-837.5-883.8-796.4-439.3-245.5

None

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-600000.0-289000.0-684000.0-29000.0-74000.0-997000.0-49000.0-11091000.0-91000.0-41000.0-112000.0-34000.0-43000.0-37000.0-47000.0-34000.0-78000.0-32000.0
Percentage of NetIncomeLossAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-1.5-0.6-2.0-0.1-0.3-3.9-0.2-60.2-0.8-0.1-0.8-0.2-0.9-0.8-0.9-0.6-1.5-0.7

None

us-gaap:Assets

us-gaap:Assets


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value298297309287322220231244177197140148157105
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Assets us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value6159524635413628242323154.308
Percentage of Assets20.520.016.816.311.018.615.811.713.811.716.610.44.1
Percentage of Assets20.520.016.816.311.018.615.811.713.811.716.610.44.1
Percentage of Assets atnx:CommercialPlatform100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value97816365676558515050514748
Percentage of Assets32.827.520.522.920.829.725.521.028.625.736.432.245.9
Percentage of Assets32.827.520.522.920.829.725.521.028.625.736.432.245.9
Percentage of Assets atnx:GlobalSupplyChainPlatform100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value139156194174219113135164102123658553
Percentage of Assets46.752.562.760.868.251.758.867.357.662.647.057.450.1
Percentage of Assets46.752.562.760.868.251.758.867.357.662.647.057.450.1
Percentage of Assets atnx:OncologyInnovationPlatform100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:Liabilities

us-gaap:Liabilities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value17113913415215512410292524149333771
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets57.646.943.353.148.156.644.337.829.821.035.422.823.767.3

None

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value298297309287322220231244177197140148157105
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1391701881461781071391621231559011411933
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets46.757.460.750.955.548.660.366.569.978.764.176.775.731.9

None

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value216217230213249150170187119140839310251
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets72.773.274.574.377.568.473.976.867.470.959.762.564.849.0

None

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value1057112761967149511439391955263343264317
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets35.524.241.221.430.032.221.520.97.919.928.012.934.90.031.30.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType

atnx:Dunkirk, us-gaap:ManufacturingFacility


None
Period End2020-03-31
Value8.7
Percentage of CashAndCashEquivalentsAtCarryingValue12.1
Percentage of Assets2.9
Percentage of Assets atnx:Dunkirk us-gaap:ManufacturingFacility0.0

None

us-gaap:ShortTermInvestments

us-gaap:ShortTermInvestments


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value10413342430.341579066671149308.628
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.514.010.714.713.60.224.936.937.634.08.433.519.18.1

None

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value385116179.56420127.0715.1387.8458.4686.4593.7832.777
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets13.017.35.46.03.09.35.62.92.94.06.04.32.42.6

us-gaap:AccountsReceivableNetCurrent us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value261915124.714125.1463.723.3944.5783.95
Percentage of AccountsReceivableNetCurrent67.638.791.372.249.361.839.752.666.158.446.6
Percentage of Assets8.86.74.94.31.55.82.21.51.92.32.8
Percentage of Assets atnx:CommercialPlatform42.733.529.226.513.331.014.113.013.819.816.9

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1.4461.3881.4074.7684.857.8637.8053.3421.7233.2474.469
Percentage of AccountsReceivableNetCurrent3.72.78.427.850.738.260.347.333.541.452.8
Percentage of Assets0.50.50.51.71.53.63.41.41.01.63.2
Percentage of Assets atnx:GlobalSupplyChainPlatform1.51.72.27.27.212.013.36.53.46.48.7

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-12-312018-09-302018-06-302018-03-312017-12-31
Value11300.0490.0090.0210.0190.049
Percentage of AccountsReceivableNetCurrent28.658.60.30.10.40.20.6
Percentage of Assets3.710.10.00.00.00.00.0
Percentage of Assets atnx:OncologyInnovationPlatform7.919.30.00.00.00.00.1

None

us-gaap:InventoryNet

us-gaap:InventoryNet


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value3135322827252825211816119.264.24
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets10.412.010.59.98.511.412.510.312.39.411.87.85.94.0

None

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1917203846332113117.1987.6925.8763.9783.153
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.65.76.713.514.615.29.45.76.73.65.54.02.53.0

None

us-gaap:AmortizationOfIntangibleAssets

us-gaap:AmortizationOfIntangibleAssets


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value500000.0500000.0500000.0500000.0500000.0500000.0400000.0400000.0400000.0400000.0400000.0400000.0400000.0400000.0300000.0200000.0100000.0
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value262423191612111110109.6518.8248.3215.81
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets9.08.37.56.75.15.65.04.65.95.26.95.95.35.5

us-gaap:PropertyPlantAndEquipmentNet us-gaap:StatementGeographical

country:CN


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1412118.4817.2214.9664.8984.7164.6724.7564.3464.2154.0413.633
Percentage of PropertyPlantAndEquipmentNet53.549.450.444.044.340.542.842.244.945.945.047.848.662.5
Percentage of Assets4.84.13.82.92.22.32.11.92.62.43.12.82.63.4
Percentage of Assets country:CN0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

country:US


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value121211109.0857.2836.5496.4585.7325.6125.3054.6094.282.177
Percentage of PropertyPlantAndEquipmentNet46.550.649.656.055.759.557.257.855.154.155.052.251.437.5
Percentage of Assets4.24.23.73.82.83.32.82.63.22.83.83.12.72.1
Percentage of Assets country:US0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:Goodwill

us-gaap:Goodwill


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value383838373737373737373737373737
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets12.912.912.413.011.617.116.215.321.219.226.925.323.835.50.0

None

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

atnx:CDEInProgressResearchAndDevelopment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value723000.0723000.0728000.0715000.0718000.0728000.01026000.01026000.01025000.01026000.01106000.01106000.01636000.01884000.0
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.20.20.20.20.30.40.40.60.50.80.71.01.8
Percentage of Assets atnx:CDEInProgressResearchAndDevelopment0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value8.0158.5258.5228.9729.76910107.2547.7368.2768.5728.9059.2428.464
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.72.92.73.13.04.74.73.04.44.26.16.05.98.0

None

us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsNet

atnx:PolymedCustomerList


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value0.3020.3650.4290.4920.5560.6190.6550.720.7850.8490.9180.9821.0481.179
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.20.20.30.30.30.40.40.70.70.71.1
Percentage of Assets atnx:PolymedCustomerList0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

atnx:PolymedTechnology


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value2.2952.3682.4152.5182.5412.5872.7132.7822.8192.8472.953.043.1293.275
Percentage of FiniteLivedIntangibleAssetsNet759.9648.8562.9511.8457.0417.9414.2386.4359.1335.3321.4309.6298.6277.8
Percentage of Assets0.80.80.80.90.81.21.21.11.61.42.12.02.03.1
Percentage of Assets atnx:PolymedTechnology0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:LicensingAgreements


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value5.165.5435.3745.7516.1276.5036.8752.8143.0353.2573.4773.6983.9192.785
Percentage of FiniteLivedIntangibleAssetsNet1708.61518.61252.71168.91102.01050.61049.6390.8386.6383.6378.8376.6374.0236.2
Percentage of Assets1.71.91.72.01.93.03.01.21.71.62.52.52.52.6
Percentage of Assets us-gaap:LicensingAgreements0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312019-01-01
Value7846000.08266000.08818000.08517000.08983000.09428000.09800000.0
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.62.82.83.02.84.30.0

None

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value6676718995675142473645292728
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets22.425.823.131.329.630.822.417.226.918.532.220.117.226.5

None

us-gaap:LongTermDebtCurrent

us-gaap:LongTermDebtCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312017-09-302017-06-302016-12-31
Value676000.0674000.0686000.070000.0770000.0792000.0779000.0835000.0798000.0789000.0766000.0
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.20.20.00.20.40.30.60.50.50.7

None

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value15182316152012121416166.6227.3157.174
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.36.27.55.64.89.35.65.28.18.211.94.54.66.8

None

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:AccruedIncomeTaxesCurrent


None
Period End2020-06-302020-03-312019-12-31
Value5228000.05281000.0187000.0
Percentage of AccruedIncomeTaxesCurrent100.0100.0100.0
Percentage of Assets1.81.80.1

None

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value4754446975423728261326211718
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets15.818.414.324.323.319.316.311.515.16.819.214.511.317.9

None

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


None
Period End2020-06-302020-03-312019-12-31
Value2713000.02791000.03010000.0
Percentage of OperatingLeaseLiabilityCurrent100.0100.0100.0
Percentage of Assets0.90.91.0

None

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value0.0970.0750.21820200.1310.190.3645.5261.202
Percentage of ContractWithCustomerLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.17.06.30.10.10.13.10.9

None

us-gaap:LongTermDebtNoncurrent us-gaap:LongtermDebtType

us-gaap:LongTermDebtNoncurrent

atnx:SeniorSecuredLoan


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value88464646454545
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets29.615.715.016.014.220.719.6
Percentage of Assets atnx:SeniorSecuredLoan0.00.00.00.00.00.00.0

None

us-gaap:MinorityInterest

us-gaap:MinorityInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value-13061000.0-12659000.0-12370000.0-11686000.0-11657000.0-11583000.0-10586000.0-10537000.0553000.0644000.0685000.0797000.0831000.0862000.0
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-4.4-4.3-4.0-4.1-3.6-5.3-4.6-4.30.30.30.50.50.50.8

None

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OtherLiabilitiesNoncurrent


None
Period End2020-06-302020-03-312019-12-312018-12-31
Value2607000.02585000.02563000.04847000.0
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0
Percentage of Assets0.90.90.82.1

None

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


None
Period End2020-06-302020-03-312019-12-31
Value6850000.07226000.07620000.0
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0100.0
Percentage of Assets2.32.42.5

None

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1391701881461781071391621231559011411933
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets46.757.460.750.955.548.660.366.569.978.764.176.775.731.9

None

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value1261581751341679512815212415690114120-3.6173469909827
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets42.453.156.746.951.943.455.762.270.279.064.677.276.30.032.70.00.00.00.0

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value-1.067-1.141-0.635-0.423-0.1140.415-0.656-0.62-0.0290.537-0.146-0.412-0.658-0.802-1.304-0.638-0.587-0.2230.083
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-0.8-0.7-0.4-0.3-0.10.4-0.5-0.4-0.00.3-0.2-0.4-0.522.2-3.8-0.9-0.7-0.20.3
Percentage of Assets-0.4-0.4-0.2-0.1-0.00.2-0.3-0.3-0.00.3-0.1-0.3-0.40.0-1.20.00.00.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value77576676370069759359158750149542341940223923722822420686
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest613.9484.2434.2519.2417.0620.5459.0386.1403.2317.7467.1365.4334.2-6628.9685.3327.8248.3210.8309.2
Percentage of Assets260.0257.3246.4243.4216.4269.2255.8240.2283.0251.0301.8282.2254.90.0224.40.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value0.0830.0830.0830.0790.0790.0690.0690.0680.0650.0650.060.060.0590.0420.0420.0420.0420.040.024
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.10.10.00.10.00.10.10.00.10.00.10.10.0-1.20.10.10.00.00.1
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value-13.061-12.659-12.37-11.686-11.657-11.583-10.586-10.5370.5530.6440.6850.7970.8310.8740.8620.9090.8930.484
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-10.3-8.0-7.0-8.7-7.0-12.1-8.2-6.90.40.40.80.70.7-24.22.51.31.00.5
Percentage of Assets-4.4-4.3-4.0-4.1-3.6-5.3-4.6-4.30.30.30.50.50.50.00.80.00.00.0
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value13917018814617810713916212315590114119-4.4913368899727
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest110.3108.0107.0108.7107.0112.1108.2106.999.699.699.299.399.3124.297.598.799.099.5100.0
Percentage of Assets46.757.460.750.955.548.660.366.569.978.764.176.775.70.031.90.00.00.00.0
Percentage of Assets us-gaap:Parent0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value-627.345-586.894-567.465-545.738-510.98-478.949-443.716-416.603-370.433-333.574-326.276-297.993-274.719-236.094-195.106-155.052-130.43-107.391-56.791
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-496.9-370.9-322.7-404.8-305.6-501.1-344.6-274.0-297.8-213.7-359.6-259.3-228.26527.3-562.8-222.8-144.5-109.5-204.0
Percentage of Assets-210.5-197.1-183.1-189.8-158.6-217.4-192.0-170.4-208.9-168.9-232.4-200.3-174.10.0-184.30.00.00.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TreasuryStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-7.406-3.856-3.761-1.545-1.545
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-5.9-4.7-4.2-5.5-4.4-7.7-5.8-4.9-6.0-4.7-8.2-6.4-6.2204.8-21.4-5.5-4.2-1.6-5.6
Percentage of Assets-2.5-2.5-2.4-2.6-2.3-3.4-3.2-3.0-4.2-3.7-5.3-5.0-4.70.0-7.00.00.00.00.0
Percentage of Assets us-gaap:TreasuryStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:CommonStockValue

us-gaap:CommonStockValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value83000.083000.083000.079000.079000.069000.069000.068000.065000.065000.060000.060000.059000.042000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:AdditionalPaidInCapitalCommonStock

us-gaap:AdditionalPaidInCapitalCommonStock


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value775766763700697593591587501495423419402237
Percentage of AdditionalPaidInCapitalCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets260.0257.3246.4243.4216.4269.2255.8240.2283.0251.0301.8282.2254.9224.4

None

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value-627340000.0-586890000.0-567460000.0-545740000.0-510980000.0-478950000.0-443720000.0-416600000.0-370430000.0-333570000.0-326280000.0-297990000.0-274720000.0-195110000.0
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-210.5-197.1-183.1-189.8-158.6-217.4-192.0-170.4-208.9-168.9-232.4-200.3-174.1-184.3

None

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value-1067000.0-1141000.0-635000.0-423000.0-114000.0415000.0-656000.0-620000.0-29000.0537000.0-146000.0-412000.0-658000.0-1304000.0
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-0.4-0.4-0.2-0.1-0.00.2-0.3-0.3-0.00.3-0.1-0.3-0.4-1.2

None

us-gaap:MinorityInterest

us-gaap:MinorityInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value-13061000.0-12659000.0-12370000.0-11686000.0-11657000.0-11583000.0-10586000.0-10537000.0553000.0644000.0685000.0797000.0831000.0862000.0
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-4.4-4.3-4.0-4.1-3.6-5.3-4.6-4.30.30.30.50.50.50.8

None

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-24523000.0-45545000.0-23340000.0-36347000.0-4802000.0-32971000.0-34072000.0-37286000.0-25303000.0-12726000.0-17868000.0-14841000.0
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-61.0-97.0-67.9-187.7-21.6-130.3-160.2-202.3-218.8-33.6-120.1-106.1

None

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value28-10.4514.911-2.176-47.4345232-24.5720.247-56.837-20.485
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues71.1-22.314.3-11.2-213.7206.3151.2-133.32.1-150.1248.8-146.4

None

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value400.732593.3531030.9760.671990.118680.803-0.698
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues101.71.6172.917.3467.33.93.2538.71.0182.35.4-5.0

None

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-24523000.0-45545000.0-23340000.0-36347000.0-4802000.0-32971000.0-34072000.0-37286000.0-25303000.0-12726000.0-17868000.0-14841000.0
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-61.0-97.0-67.9-187.7-21.6-130.3-160.2-202.3-218.8-33.6-120.1-106.1

None

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-40451000.0-19429000.0-21727000.0-34758000.0-32031000.0-35233000.0-27113000.0-46171000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0-12421000.0-10618000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-100.7-41.4-63.2-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4-239.2-229.4

us-gaap:NetIncomeLoss us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments

atnx:CIDALLimited, atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-31
Value-1100000.0-1000000.0
Percentage of NetIncomeLoss2.75.1
Percentage of Revenues-2.7-2.1
Percentage of Revenues atnx:CIDALLimited atnx:OncologyInnovationPlatform0.00.0

us-gaap:NetIncomeLoss us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value318000.0-12485000.0-2552000.0-6863000.0
Percentage of NetIncomeLoss-0.864.38.019.5
Percentage of Revenues0.8-26.6-11.5-27.1
Percentage of Revenues atnx:CommercialPlatform0.00.00.00.0

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-5745000.0-5986000.0313000.0-767000.0
Percentage of NetIncomeLoss14.230.8-1.02.2
Percentage of Revenues-14.3-12.81.4-3.0
Percentage of Revenues atnx:GlobalSupplyChainPlatform0.00.00.00.0

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value-35024000.0-958000.0-29792000.0-27603000.0
Percentage of NetIncomeLoss86.64.993.078.3
Percentage of Revenues-87.2-2.0-134.2-109.1
Percentage of Revenues atnx:OncologyInnovationPlatform0.00.00.00.0

None

us-gaap:ProfitLoss

us-gaap:ProfitLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-41051000.0-19718000.0-22411000.0-34787000.0-32105000.0-36230000.0-27162000.0-57262000.0-36950000.0-7339000.0-28395000.0-23308000.0-38668000.0-41025000.0-40101000.0-24656000.0-12499000.0-10650000.0
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-102.2-42.0-65.2-179.6-144.6-143.2-127.7-310.7-319.5-19.4-190.9-166.6-841.5-895.5-784.3-439.0-240.7-230.1

us-gaap:ProfitLoss us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-600000.0-289000.0-29000.0-74000.0-997000.0-49000.0-11090000.0-91000.0-41000.0-112000.0-34000.0-43000.0-37000.0-47000.0-34000.0
Percentage of ProfitLoss1.51.50.10.22.80.219.40.20.60.40.10.10.10.10.1
Percentage of Revenues-1.5-0.6-0.1-0.3-3.9-0.2-60.2-0.8-0.1-0.8-0.2-0.9-0.8-0.9-0.6
Percentage of Revenues us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-40451000.0-19429000.0-34758000.0-32031000.0-35233000.0-27113000.0-46170000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0
Percentage of ProfitLoss98.598.599.999.897.299.880.699.899.499.699.999.999.999.999.9
Percentage of Revenues-100.7-41.4-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4
Percentage of Revenues us-gaap:Parent0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-40451000.0-19429000.0-34758000.0-32031000.0-35233000.0-27113000.0-46170000.0-36859000.0-7298000.0-28283000.0-23274000.0-38625000.0-40988000.0-40054000.0-24622000.0
Percentage of ProfitLoss98.598.599.999.897.299.880.699.899.499.699.999.999.999.999.9
Percentage of Revenues-100.7-41.4-179.5-144.3-139.2-127.5-250.5-318.7-19.3-190.2-166.3-840.6-894.7-783.4-438.4
Percentage of Revenues us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

None

us-gaap:DepreciationDepletionAndAmortization

us-gaap:DepreciationDepletionAndAmortization


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value1035000.01086000.01009000.01001000.0928000.0879000.0845000.0909000.0947000.0868000.01088000.0921000.0848000.0816000.0696000.0578000.0335000.0
Percentage of DepreciationDepletionAndAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DepreciationDepletionAndAmortization us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value421000.0415000.0396000.0398000.0393000.0379000.0242000.0245000.0245000.0245000.0245000.0243000.0233000.0198000.0142000.045000.0
Percentage of DepreciationDepletionAndAmortization40.738.239.239.842.343.128.627.025.928.222.526.427.524.320.47.8

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value426000.0496000.0477000.0376000.0325000.0311000.0418000.0490000.0527000.0467000.0703000.0548000.0495000.0526000.0505000.0484000.0
Percentage of DepreciationDepletionAndAmortization41.245.747.337.635.035.449.553.955.653.864.659.558.464.572.683.7

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value188000.0175000.0136000.0227000.0210000.0189000.0185000.0174000.0175000.0156000.0140000.0130000.0120000.092000.049000.049000.0
Percentage of DepreciationDepletionAndAmortization18.216.113.522.722.621.521.919.118.518.012.914.114.211.37.08.5

None

us-gaap:IncreaseDecreaseInInventories

us-gaap:IncreaseDecreaseInInventories


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-4.5883.1014.181.2122.048-3.5963.5563.4283.2322.014.9262.3752.4252.5950.024-0.121
Percentage of IncreaseDecreaseInInventories100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value3.0532.2612.6622.1483.2971.7782.3522.4153.5432.7012.8812.896.6752.1459.3424.126
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value28-10.4514.911-2.176-47.4345232-24.5720.247-56.837-20.485
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues71.1-22.314.3-11.2-213.7206.3151.2-133.32.1-150.1248.8-146.4

None

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value2.831.7365.0593.6223.9730.9180.820.8660.4581.1771.0560.9421.8881.5540.3670.614
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value400.732593.3531030.9760.671990.118680.803-0.698
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues101.71.6172.917.3467.33.93.2538.71.0182.35.4-5.0

None

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:ProceedsFromIssuanceOfLongTermDebt


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value940.4350.02.8152.9060.7430.0
Percentage of ProceedsFromIssuanceOfLongTermDebt100.0100.00.0100.0100.0100.00.0

None

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value111010111111101011101010109.280689
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value9.178.878.888.838.818.788.518.538.387.987.197.026.966.26
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

None

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

us-gaap:RestrictedStock


None
Period End2020-06-302020-03-312019-12-31
Value001000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod0.00.0100.0

atnx:AccruedPurchasesOfPropertyAndEquipment

atnx:AccruedPurchasesOfPropertyAndEquipment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-573000.01009000.0-623000.0-68000.0540000.0634000.0-105000.0312000.029000.0104000.06000.070000.0-1000000.01080000.0291000.0-19000.0
Percentage of AccruedPurchasesOfPropertyAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:NumberOfTranches us-gaap:TypeOfArrangement

atnx:NumberOfTranches

atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value5.0
Percentage of NumberOfTranches100.0

atnx:PaymentsForLicenses

atnx:PaymentsForLicenses


None
Period End2020-06-302020-03-312019-06-302019-03-312017-12-312016-12-31
Value19000.064000.004175000.000
Percentage of PaymentsForLicenses100.0100.00.0100.00.00.0

atnx:PercentageOfCommonStockIssuedShares us-gaap:RelatedPartyTransactionsByRelatedParty

atnx:PercentageOfCommonStockIssuedShares

atnx:AvalonBioMedical


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312017-09-30
Value00.010000.010-0.001-0.001
Percentage of PercentageOfCommonStockIssuedShares0.0100.00.00.00.0100.00.0100.0100.0

atnx:ProvisionForChargebacks us-gaap:StatementBusinessSegments

atnx:ProvisionForChargebacks

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value20242720201710105.15.04.73.30.20.1
Percentage of ProvisionForChargebacks100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:RepaymentOfFinanceLeaseObligationsAndLongTermDebt

atnx:RepaymentOfFinanceLeaseObligationsAndLongTermDebt


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value540.0470.8360.0290.0620.045-0.0070.0360.1780.337
Percentage of RepaymentOfFinanceLeaseObligationsAndLongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition


None
Period End2020-06-302020-03-312018-03-31
Value413000.0397000.0540000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312018-03-31
Value413000.0397000.0540000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition100.0100.0100.0

us-gaap:Parent


None
Period End2020-06-302020-03-312018-03-31
Value413000.0397000.0540000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value2640000.01864000.03382000.01693000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition100.0100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value2640000.01864000.03382000.01693000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition100.0100.0100.0100.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value2640000.01864000.03382000.01693000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition100.0100.0100.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued


None
Period End2020-06-302018-12-312018-09-30
Value5342000.003140000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalWarrantIssued100.00.0100.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302018-12-312018-09-30
Value5342000.003140000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalWarrantIssued100.00.0100.0

us-gaap:Parent


None
Period End2020-06-302018-12-312018-09-30
Value5342000.003140000.0
Percentage of AdjustmentsToAdditionalPaidInCapitalWarrantIssued100.00.0100.0

us-gaap:AmortizationOfDebtDiscountPremium

us-gaap:AmortizationOfDebtDiscountPremium


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value297000.0256000.0256000.0257000.0256000.0257000.0258000.00
Percentage of AmortizationOfDebtDiscountPremium100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value44-55.26440-35.175120-1.23937-24.938-0.54519-36.024
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConcentrationRiskPercentage1 us-gaap:ConcentrationRiskByType, us-gaap:ConcentrationRiskByBenchmark, us-gaap:MajorCustomers, us-gaap:StatementBusinessSegments

us-gaap:ConcentrationRiskPercentage1

us-gaap:CustomerConcentrationRisk, us-gaap:AccountsReceivable, atnx:CustomerA, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-03-312018-03-31
Value0.580.320.07
Percentage of ConcentrationRiskPercentage1100.0100.0100.0

us-gaap:CustomerConcentrationRisk, us-gaap:AccountsReceivable, atnx:CustomerB, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-03-312018-03-31
Value0.140.190.14
Percentage of ConcentrationRiskPercentage124.159.4200.0

us-gaap:CustomerConcentrationRisk, us-gaap:AccountsReceivable, atnx:CustomerC, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-03-312018-03-31
Value0.130.10.22
Percentage of ConcentrationRiskPercentage122.431.2314.3

us-gaap:CustomerConcentrationRisk, us-gaap:AccountsReceivable, atnx:CustomerD, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-03-31
Value0.080.07
Percentage of ConcentrationRiskPercentage113.821.9

us-gaap:CustomerConcentrationRisk, us-gaap:SalesRevenueNet, atnx:CustomerA, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-06-302017-03-31
Value0.60.170.190.220.270.250.030.130.28
Percentage of ConcentrationRiskPercentage1103.40.00.068.80.00.042.90.00.0

us-gaap:CustomerConcentrationRisk, us-gaap:SalesRevenueNet, atnx:CustomerB, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-03-31
Value0.110.220.180.210.130.160.030.050.22
Percentage of ConcentrationRiskPercentage119.00.00.065.60.00.042.90.00.0

us-gaap:CustomerConcentrationRisk, us-gaap:SalesRevenueNet, atnx:CustomerC, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value0.090.170.070.210.120.110.10.160.07
Percentage of ConcentrationRiskPercentage115.50.00.065.60.00.0142.90.00.0

us-gaap:CustomerConcentrationRisk, us-gaap:SalesRevenueNet, atnx:CustomerD, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-03-312019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value0.070.120.110.10.660.050.15
Percentage of ConcentrationRiskPercentage112.137.50.00.0942.90.00.0

us-gaap:ConcentrationRiskPercentage1 us-gaap:MajorCustomers, us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType, us-gaap:StatementBusinessSegments

atnx:CustomerA, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-06-302019-06-302017-09-302016-09-30
Value0.3200.180.38
Percentage of ConcentrationRiskPercentage10.00.00.00.0

atnx:CustomerB, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-06-302019-06-302017-09-302016-09-30
Value0.150.190.070.27
Percentage of ConcentrationRiskPercentage10.00.00.00.0

atnx:CustomerC, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-06-302019-06-302017-09-30
Value0.140.070.16
Percentage of ConcentrationRiskPercentage10.00.00.0

atnx:CustomerD, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk, atnx:CommercialPlatformAndGlobalSupplyChain


None
Period End2020-06-302019-06-302017-09-30
Value0.090.180.07
Percentage of ConcentrationRiskPercentage10.00.00.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:TimingOfTransferOfGoodOrService, us-gaap:ProductOrService

us-gaap:ContractWithCustomerLiabilityRevenueRecognized

us-gaap:TransferredAtPointInTime, atnx:LicensedIP


None
Period End2020-03-312019-03-31
Value280.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized100.00.0

us-gaap:DeferredIncomeTaxesAndTaxCredits

us-gaap:DeferredIncomeTaxesAndTaxCredits


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3000.048000.0000486000.0-49000.0-21000.026000.0-321000.0
Percentage of DeferredIncomeTaxesAndTaxCredits100.0100.00.00.00.0100.0100.0100.0100.0100.0

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EarningsPerShareBasicAndDiluted


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-0.5-0.24-0.28-0.45-0.44-0.53-0.41-0.7-0.58-0.12-0.49-0.41-0.88-1.01-0.98-0.61-0.31-0.27
Percentage of EarningsPerShareBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value24000.0-427000.0-203000.0-123000.0-291000.01006000.0-75000.0-367000.0-211000.0478000.083000.0136000.0
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseInterestExpense

us-gaap:FinanceLeaseInterestExpense


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-31
Value20000.06000.07000.08000.09000.0
Percentage of FinanceLeaseInterestExpense100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseRightOfUseAssetAmortization

us-gaap:FinanceLeaseRightOfUseAssetAmortization


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-31
Value64000.034000.021000.014000.012000.0
Percentage of FinanceLeaseRightOfUseAssetAmortization100.0100.0100.0100.0100.0

us-gaap:FinitelivedIntangibleAssetsAcquired1 us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FinitelivedIntangibleAssetsAcquired1

atnx:GlandPharmaLtd, us-gaap:LicensingAgreements


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value4400000.0004300000.0004300000.0
Percentage of FinitelivedIntangibleAssetsAcquired1100.00.00.0100.00.00.0100.0

atnx:HanmiPharmaceuticalsCoLtd, us-gaap:LicensingAgreements


None
Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value400000.000400000.000400000.0
Percentage of FinitelivedIntangibleAssetsAcquired19.10.00.09.30.00.09.3

atnx:MAIAPharmaceuticalsInc, atnx:LicensesOfOtherSpecialtyProducts


None
Period End2020-03-31
Value700000.0
Percentage of FinitelivedIntangibleAssetsAcquired115.9

atnx:MAIAPharmaceuticalsInc, us-gaap:LicensingAgreements


None
Period End2020-03-312019-09-302019-06-302019-03-31
Value4000000.0004000000.0
Percentage of FinitelivedIntangibleAssetsAcquired190.90.00.093.0

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-9.7714.43-19.113-4.59827156.565-5.59510-7.848155.123-9.487.837135.095
Percentage of IncreaseDecreaseInAccountsPayableAndAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value2.704-3.748-17.95-8.22413117.6762.0314.753-0.4941.8151.898-0.6061.43-1.0731.625
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInReceivables

us-gaap:IncreaseDecreaseInReceivables


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-12.79734-0.4797.604-11.0117.6245.881.933-2.707-0.6232.0092.6761.85-0.844-0.754-0.269
Percentage of IncreaseDecreaseInReceivables100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss

us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value9000.0-474000.080000.0-97000.0-96000.0-311000.0-3000.0-127000.0-193000.0-67000.074000.073000.0
Percentage of IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InvestmentIncomeInterest

us-gaap:InvestmentIncomeInterest


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value185000.0413000.0473000.0650000.0475000.0283000.0474000.0654000.0
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LeaseCost

us-gaap:LeaseCost


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-31
Value852000.0795000.0821000.0815000.0802000.0
Percentage of LeaseCost100.0100.0100.0100.0100.0

us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination

us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination


None
Period End2020-06-302017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value198000.000049000.0050000.0
Percentage of NoncontrollingInterestIncreaseFromBusinessCombination100.00.00.00.0100.00.0100.0

us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


None
Period End2020-06-302017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value198000.000049000.0050000.0
Percentage of NoncontrollingInterestIncreaseFromBusinessCombination100.00.00.00.0100.00.0100.0

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeaseCost


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-31
Value768000.0755000.0793000.0793000.0781000.0
Percentage of OperatingLeaseCost100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value-43000.0-438000.0-194000.0-310000.0-446000.01068000.0-48000.0-554000.0-641000.0718000.0262000.0242000.0181000.0499000.0-571000.0-50000.0-393000.0
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
Value117000.0-68000.0-18000.01000.0-83000.03000.012000.0-37000.075000.0-35000.04000.04000.0-37000.03000.0-95000.0-1000.067000.0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments

us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312018-09-30
Value3114140.05715
Percentage of ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments100.0100.0100.00.0100.0100.0

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:ProceedsFromStockOptionsExercised


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value125000.0344000.0579000.0567000.0559000.0278000.0996000.01401000.0296000.01263000.01070000.0769000.0396000.043000.036000.00
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty

atnx:ClinicalDevelopmentServices, atnx:ZenRx


None
Period End2020-06-302019-06-30
Value200000.0300000.0
Percentage of RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty100.0100.0

us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:RelatedPartyTransaction

atnx:ZenRx, atnx:ClinicalDevelopmentServices


None
Period End2020-03-312019-03-31
Value500000.0300000.0
Percentage of RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty0.00.0

us-gaap:RevenueFromRelatedParties us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

us-gaap:RevenueFromRelatedParties

atnx:SagardHealthcareRoyaltyPartnersLP, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value50
Percentage of RevenueFromRelatedParties100.0

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability


None
Period End2020-06-302020-03-312019-06-302019-03-31
Value0353000.00583000.0
Percentage of RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability0.0100.00.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value0.00590.0075-0.00010-0.00020.02630.00010.00020.00010.025700-0.0020.01940.001-0.0001
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate100.0100.0100.00.0100.0100.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-0.010.670000.640000.59000.010.6500
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate100.0100.00.00.00.0100.00.00.00.0100.00.00.0100.0100.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

us-gaap:EmployeeStockOption


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value0800000.0900000.0800000.0600000.0400000.0200000.02800000.0300000.03400000.02600000.01200000.0300000.0100000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value0.287.320.020.0108.03-0.070.040.49.430.110.410.046.450.240
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:StockIssuedDuringPeriodSharesAcquisitions us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesAcquisitions

us-gaap:CommonStock


None
Period End2020-06-30
Value51691.0
Percentage of StockIssuedDuringPeriodSharesAcquisitions100.0

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised


None
Period End2020-06-302020-03-312019-12-312019-09-302017-12-312017-09-30
Value12500.070200.0114540.075160.0226180.0106200.0
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised us-gaap:StatementEquityComponents

us-gaap:CommonStock


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312016-09-30
Value12500.070200.075160.092442.049632.00
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0100.00.00.00.0

us-gaap:StockIssuedDuringPeriodValueAcquisitions

us-gaap:StockIssuedDuringPeriodValueAcquisitions


None
Period End2020-06-302016-12-312016-09-30
Value0.2690.00.0
Percentage of StockIssuedDuringPeriodValueAcquisitions100.00.00.0

us-gaap:StockIssuedDuringPeriodValueAcquisitions us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302016-12-312016-09-30
Value0.2690.00.0
Percentage of StockIssuedDuringPeriodValueAcquisitions100.00.00.0

us-gaap:Parent


None
Period End2020-06-302016-12-312016-09-30
Value0.2690.00.0
Percentage of StockIssuedDuringPeriodValueAcquisitions100.00.00.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312016-09-30
Value125000.0344000.0567000.0559000.0278000.00
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.00.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312016-09-30
Value125000.0344000.0567000.0559000.0278000.00
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.00.0

us-gaap:Parent


None
Period End2020-06-302020-03-312019-09-302019-06-302019-03-312016-09-30
Value125000.0344000.0567000.0559000.0278000.00
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.00.0

atnx:AccruedClinicalExpensesCurrent

atnx:AccruedClinicalExpensesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-31
Value3600000.03819000.02510000.02848000.01987000.01888000.02653000.03826000.01080000.0
Percentage of AccruedClinicalExpensesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:AccruedConstructionCostsCurrent

atnx:AccruedConstructionCostsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value8.2021922324027162.709
Percentage of AccruedConstructionCostsCurrent100.0100.0100.0100.0100.0100.0100.0100.0

atnx:AccruedConstructionCostsExpectedToBeFunded us-gaap:BalanceSheetLocation, us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType

atnx:AccruedConstructionCostsExpectedToBeFunded

us-gaap:PrepaidExpensesAndOtherCurrentAssets, atnx:Dunkirk, us-gaap:ManufacturingFacility


None
Period End2020-03-31
Value10
Percentage of AccruedConstructionCostsExpectedToBeFunded100.0

atnx:AccruedConstructionCostsExpectedToBeFunded us-gaap:StatementGeographical, us-gaap:PropertyPlantAndEquipmentByType

atnx:Dunkirk, us-gaap:ManufacturingFacility


None
Period End2020-03-31
Value19
Percentage of AccruedConstructionCostsExpectedToBeFunded180.6

atnx:AccruedInventoryPurchasesCurrent

atnx:AccruedInventoryPurchasesCurrent


None
Period End2020-06-302020-03-312019-12-31
Value4774000.05792000.07194000.0
Percentage of AccruedInventoryPurchasesCurrent100.0100.0100.0

atnx:AccruedOperatingExpensesCurrent

atnx:AccruedOperatingExpensesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-31
Value2065000.02517000.01885000.05994000.05298000.03646000.08128000.01529000.01057000.0
Percentage of AccruedOperatingExpensesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:ChargebacksAndOtherDeductionsCurrent

atnx:ChargebacksAndOtherDeductionsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value12141419111013137.4163.711
Percentage of ChargebacksAndOtherDeductionsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:ChargebacksAndOtherDeductionsCurrent us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value12141419119.013137.4163.711
Percentage of ChargebacksAndOtherDeductionsCurrent100.2100.0100.0100.094.986.1100.0100.0100.0100.0

atnx:CommonStockSharesHeldByRelatedParties us-gaap:RelatedPartyTransactionsByRelatedParty

atnx:CommonStockSharesHeldByRelatedParties

atnx:AvalonBioMedical


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value786060.0786060.0786060.0786060.0786060.0786060.0786060.0786060.0786060.0678880.0678880.0678880.0678880.0678880.0
Percentage of CommonStockSharesHeldByRelatedParties100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:CurrentPortionOfFinanceAndCapitalLeaseObligation

atnx:CurrentPortionOfFinanceAndCapitalLeaseObligation


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value361000.0197000.0194000.0191000.0188000.0185000.0182000.0
Percentage of CurrentPortionOfFinanceAndCapitalLeaseObligation100.0100.0100.0100.0100.0100.0100.0

atnx:DebtCurrentAndNonCurrent

atnx:DebtCurrentAndNonCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312017-09-302017-06-302016-12-31
Value1056363646147461.9811.88.76141
Percentage of DebtCurrentAndNonCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:IndefiniteLivedIntangibleAssetsExcludingGoodwillNetCarryingAmount us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

atnx:IndefiniteLivedIntangibleAssetsExcludingGoodwillNetCarryingAmount

atnx:CDEInProgressResearchAndDevelopment


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value723000.0723000.0728000.0715000.0718000.0728000.0728000.01026000.01025000.01026000.01026000.01026000.01490000.01636000.0
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwillNetCarryingAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

atnx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour

atnx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour


None
Period End2020-06-30
Value1950000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour100.0

atnx:LineOfCreditFacilityRemainingBorrowingCapacityOfContingentMilestoneBased us-gaap:TypeOfArrangement

atnx:LineOfCreditFacilityRemainingBorrowingCapacityOfContingentMilestoneBased

atnx:RevenueInterestFinancingAgreement


None
Period End2020-06-30
Value50
Percentage of LineOfCreditFacilityRemainingBorrowingCapacityOfContingentMilestoneBased100.0

atnx:SeniorCreditAgreement


None
Period End2020-06-30
Value125
Percentage of LineOfCreditFacilityRemainingBorrowingCapacityOfContingentMilestoneBased250.0

atnx:LongTermDebtAndFinanceLeaseObligationsNonCurrent

atnx:LongTermDebtAndFinanceLeaseObligationsNonCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value95525252494645
Percentage of LongTermDebtAndFinanceLeaseObligationsNonCurrent100.0100.0100.0100.0100.0100.0100.0

atnx:LongTermPortionOfFinanceAndCapitalLeaseLbligation

atnx:LongTermPortionOfFinanceAndCapitalLeaseLbligation


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value506000.0177000.0227000.0277000.0326000.0374000.0422000.0
Percentage of LongTermPortionOfFinanceAndCapitalLeaseLbligation100.0100.0100.0100.0100.0100.0100.0

atnx:PercentageOfInternalRateOfReturnOfProductPayment us-gaap:StatementScenario, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

atnx:PercentageOfInternalRateOfReturnOfProductPayment

atnx:PaymentsAtRepurchasePriceAfterAugustFourTwentyTwentyFourAndOnOrBeforeAugustFourTwentyTwentyFive, atnx:SagardHealthcareRoyaltyPartnersLP, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value0.15
Percentage of PercentageOfInternalRateOfReturnOfProductPayment100.0

atnx:PaymentsAtRepurchasePriceAfterAugustFourTwentyTwentyThreeAndOnOrBeforeAugustFourTwentyTwentyFour, atnx:SagardHealthcareRoyaltyPartnersLP, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value0.16
Percentage of PercentageOfInternalRateOfReturnOfProductPayment106.7

atnx:PaymentsAtRepurchasePriceOnOrBeforeAugustFourTwentyTwentyThree, atnx:SagardHealthcareRoyaltyPartnersLP, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value0.18
Percentage of PercentageOfInternalRateOfReturnOfProductPayment120.0

atnx:RevenueToBeRecognizedUponSatisfactionOfPerformanceObligation us-gaap:StatementBusinessSegments

atnx:RevenueToBeRecognizedUponSatisfactionOfPerformanceObligation

atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312019-12-312019-09-302019-06-30
Value0.10.20.10.2
Percentage of RevenueToBeRecognizedUponSatisfactionOfPerformanceObligation100.0100.0100.0100.0

us-gaap:AccountsReceivableGrossCurrent

us-gaap:AccountsReceivableGrossCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value5166313721312620121012
Percentage of AccountsReceivableGrossCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccountsReceivableGrossCurrent us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value3834293216231816107.0577.661
Percentage of AccountsReceivableGrossCurrent75.552.495.086.976.774.670.083.385.967.962.5

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1.5651.5051.5224.8885.0027.8767.8143.3691.7493.324.553
Percentage of AccountsReceivableGrossCurrent3.02.34.913.123.325.430.016.613.931.937.1

atnx:OncologyInnovationPlatform


None
Period End2020-06-302020-03-312019-12-312018-09-302018-06-302018-03-312017-12-31
Value11300.0490.0090.0210.0190.049
Percentage of AccountsReceivableGrossCurrent21.445.30.20.00.20.20.4

us-gaap:AccruedExchangeFeeRebateCurrent

us-gaap:AccruedExchangeFeeRebateCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value103.9631.5771.4360.9621.910.4230.788
Percentage of AccruedExchangeFeeRebateCurrent100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccruedRoyaltiesCurrent

us-gaap:AccruedRoyaltiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-31
Value0.3840.3840.3840.3820.5060.6544.8275.72912
Percentage of AccruedRoyaltiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value163000.0130000.0124000.0133000.0167000.08000.09000.027000.026000.084000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent us-gaap:MajorCustomers

atnx:DrugManufacturers


None
Period End2020-03-31
Value100000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent76.9

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent us-gaap:MajorCustomers, us-gaap:Range

atnx:HospitalsAndEndUsers, srt:Maximum


None
Period End2020-03-31
Value100000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent76.9

atnx:PharmaceuticalWholesalers, srt:Maximum


None
Period End2020-03-31
Value100000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent76.9

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent us-gaap:StatementBusinessSegments

atnx:CommercialPlatform


None
Period End2020-06-302020-03-312019-12-31
Value45000.014000.010000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent27.610.88.1

atnx:GlobalSupplyChainPlatform


None
Period End2020-06-302020-03-312019-12-312018-12-312018-09-302018-06-302017-12-31
Value118000.0116000.0114000.09000.027000.026000.084000.0
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent72.489.291.9100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure

us-gaap:AssetsFairValueDisclosure


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value848910463950.34163100719636596915
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure us-gaap:CashAndCashEquivalents, us-gaap:FairValueByAssetClass

us-gaap:CashAndCashEquivalents, us-gaap:CertificatesOfDeposit


None
Period End2020-06-302019-12-31
Value1515
Percentage of AssetsFairValueDisclosure18.014.4

us-gaap:CashAndCashEquivalents, us-gaap:CommercialPaper


None
Period End2020-06-302019-12-31
Value2451
Percentage of AssetsFairValueDisclosure29.648.7

us-gaap:CashAndCashEquivalents, us-gaap:MoneyMarketFunds


None
Period End2020-06-302019-12-31
Value135.46
Percentage of AssetsFairValueDisclosure16.35.2

us-gaap:CashAndCashEquivalents, us-gaap:USTreasuryAndGovernment


None
Period End2020-06-30
Value19
Percentage of AssetsFairValueDisclosure23.7

us-gaap:AssetsFairValueDisclosure us-gaap:CashAndCashEquivalents, us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:CashAndCashEquivalents, us-gaap:CertificatesOfDeposit, us-gaap:FairValueInputsLevel2


None
Period End2020-06-302019-12-31
Value1515
Percentage of AssetsFairValueDisclosure18.014.4

us-gaap:CashAndCashEquivalents, us-gaap:CommercialPaper, us-gaap:FairValueInputsLevel2


None
Period End2020-06-302019-12-31
Value2451
Percentage of AssetsFairValueDisclosure29.648.7

us-gaap:CashAndCashEquivalents, us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1


None
Period End2020-06-302019-12-31
Value135.46
Percentage of AssetsFairValueDisclosure16.35.2

us-gaap:CashAndCashEquivalents, us-gaap:USTreasuryAndGovernment, us-gaap:FairValueInputsLevel2


None
Period End2020-06-30
Value19
Percentage of AssetsFairValueDisclosure23.7

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:CashAndCashEquivalents

us-gaap:CertificatesOfDeposit, us-gaap:CashAndCashEquivalents


None
Period End2020-03-312019-12-31
Value1515
Percentage of AssetsFairValueDisclosure17.014.4

us-gaap:CommercialPaper, us-gaap:CashAndCashEquivalents


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value255121295.3965.74
Percentage of AssetsFairValueDisclosure28.748.733.330.88.615.5

us-gaap:MoneyMarketFunds, us-gaap:CashAndCashEquivalents


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value6.6165.460.0325.1030.02513
Percentage of AssetsFairValueDisclosure7.45.20.15.30.037.4

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType

us-gaap:AvailableforsaleSecurities, us-gaap:FairValueInputsLevel1, us-gaap:ShortTermInvestments


None
Period End2020-06-302019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value0.270.250.2510.2650.3410.3880.328
Percentage of AssetsFairValueDisclosure0.30.20.40.3100.00.60.9

us-gaap:CertificatesOfDeposit, us-gaap:FairValueInputsLevel2, us-gaap:ShortTermInvestments


None
Period End2020-06-302019-12-312019-09-30
Value101010.0
Percentage of AssetsFairValueDisclosure12.09.615.8

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:InvestmentType

us-gaap:AvailableforsaleSecurities, us-gaap:ShortTermInvestments


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value0.270.1510.250.2510.2650.3410.3880.328
Percentage of AssetsFairValueDisclosure0.30.20.20.40.3100.00.60.9

us-gaap:CertificatesOfDeposit, us-gaap:ShortTermInvestments


None
Period End2020-06-302020-03-312019-12-312019-09-30
Value10101010.0
Percentage of AssetsFairValueDisclosure12.011.39.615.8

us-gaap:CommercialPaper, us-gaap:ShortTermInvestments


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value31223243369.242
Percentage of AssetsFairValueDisclosure35.321.850.545.458.025.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueInputsLevel1


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value146.7675.710.2835.3680.3410.4135.4273.4078.441148.0312215
Percentage of AssetsFairValueDisclosure16.67.65.50.45.6100.00.75.44.88.838.313.432.3100.0

us-gaap:FairValueInputsLevel2


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value708299639062956787225147
Percentage of AssetsFairValueDisclosure83.492.494.599.694.499.394.695.291.261.786.667.7

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByAssetClass, us-gaap:CashAndCashEquivalents

us-gaap:FairValueInputsLevel1, us-gaap:MoneyMarketFunds, us-gaap:CashAndCashEquivalents


None
Period End2020-03-312018-12-31
Value6.6160.025
Percentage of AssetsFairValueDisclosure7.40.0

us-gaap:FairValueInputsLevel2, us-gaap:CertificatesOfDeposit, us-gaap:CashAndCashEquivalents


None
Period End2020-03-31
Value15
Percentage of AssetsFairValueDisclosure17.0

us-gaap:FairValueInputsLevel2, us-gaap:CommercialPaper, us-gaap:CashAndCashEquivalents


None
Period End2020-03-312018-12-31
Value255.396
Percentage of AssetsFairValueDisclosure28.78.6

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByAssetClass, us-gaap:InvestmentType

us-gaap:FairValueInputsLevel1, us-gaap:AvailableforsaleSecurities, us-gaap:ShortTermInvestments


None
Period End2020-03-312018-12-31
Value0.1510.388
Percentage of AssetsFairValueDisclosure0.20.6

us-gaap:FairValueInputsLevel2, us-gaap:CertificatesOfDeposit, us-gaap:ShortTermInvestments


None
Period End2020-03-31
Value10
Percentage of AssetsFairValueDisclosure11.3

us-gaap:FairValueInputsLevel2, us-gaap:CommercialPaper, us-gaap:ShortTermInvestments


None
Period End2020-03-312018-12-31
Value3136
Percentage of AssetsFairValueDisclosure35.358.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value116711278612271495114393919553343
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType

us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

atnx:SagardAndIMCOInvestors, us-gaap:SubsequentEvent


None
Period End2020-08-04
Value12.63
Percentage of ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1100.0

us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 us-gaap:StatementEquityComponents, us-gaap:TypeOfArrangement

us-gaap:CommonStock, atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value12.63
Percentage of ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights10.0

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiability


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value0.0970.0750.21820200.1310.190.3645.5265.741.202
Percentage of ContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability us-gaap:DeferredRevenueArrangementType, us-gaap:StatementBusinessSegments

atnx:OutLicenseRevenue, atnx:GlobalSupplyChainPlatform


None
Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value0.10.20.10.20.2
Percentage of ContractWithCustomerLiability133.391.70.51.0105.3

us-gaap:DebtInstrumentFaceAmount us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

us-gaap:DebtInstrumentFaceAmount

atnx:SagardAndIMCOInvestors, us-gaap:SubsequentEvent, atnx:SeniorCreditAgreement


None
Period End2020-08-04
Value50
Percentage of DebtInstrumentFaceAmount100.0

us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet us-gaap:DebtInstrument

us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet

atnx:SeniorSecuredLoan


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value113.3363.5923.8494.1054.3624.619
Percentage of DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredRevenueCurrent

us-gaap:DeferredRevenueCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-03-312017-12-312016-12-31
Value0.0970.0750.21820200.1310.195.741.2020.237
Percentage of DeferredRevenueCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DueToRelatedPartiesNoncurrent us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

us-gaap:DueToRelatedPartiesNoncurrent

atnx:SagardHealthcareRoyaltyPartnersLP, us-gaap:SubsequentEvent, atnx:RevenueInterestFinancingAgreement


None
Period End2020-08-04
Value85
Percentage of DueToRelatedPartiesNoncurrent100.0

us-gaap:DueToRelatedPartiesNoncurrent us-gaap:StatementScenario, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

srt:ScenarioForecast, atnx:SagardHealthcareRoyaltyPartnersLP, atnx:RevenueInterestFinancingAgreement


None
Period End2026-08-042024-09-30
Value5020
Percentage of DueToRelatedPartiesNoncurrent0.00.0

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-31
Value118.9747.5416.2775.1886.5085.0613.8171.828
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseLiability

us-gaap:FinanceLeaseLiability


None
Period End2020-06-30
Value867000.0
Percentage of FinanceLeaseLiability100.0

us-gaap:FinanceLeaseLiabilityCurrent

us-gaap:FinanceLeaseLiabilityCurrent


None
Period End2020-06-30
Value361000.0
Percentage of FinanceLeaseLiabilityCurrent100.0

us-gaap:FinanceLeaseLiabilityNoncurrent

us-gaap:FinanceLeaseLiabilityNoncurrent


None
Period End2020-06-30
Value506000.0
Percentage of FinanceLeaseLiabilityNoncurrent100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value7066000.06528000.06382000.05839000.05312000.04826000.04260000.03870000.03514000.03168000.02742000.02335000.01224000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization us-gaap:FiniteLivedIntangibleAssetsByMajorClass

atnx:PolymedCustomerList


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1291000.01228000.01164000.01101000.01037000.0974000.0938000.0873000.0808000.0744000.0675000.0611000.0545000.0414000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization18.318.818.218.919.520.222.022.623.023.524.626.20.033.8

atnx:PolymedTechnology


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1417000.01344000.01297000.01194000.01171000.01125000.0999000.0930000.0893000.0865000.0762000.0672000.0583000.0437000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization20.120.620.320.422.023.323.524.025.427.327.828.80.035.7

us-gaap:LicensingAgreements


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value4358000.03956000.03561000.03184000.02808000.02432000.02060000.01836000.01615000.01393000.01173000.0952000.0731000.0315000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization61.760.655.854.552.950.448.447.446.044.042.840.80.025.7

us-gaap:FiniteLivedIntangibleAssetsGross us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsGross

us-gaap:LicensingAgreements


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value9518000.09499000.08935000.08935000.08935000.08935000.08935000.04650000.04650000.04650000.04650000.04650000.04650000.03100000.0
Percentage of FiniteLivedIntangibleAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:IntangibleAssetsGrossExcludingGoodwill


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1515151415151511111111111110
Percentage of IntangibleAssetsGrossExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryFinishedGoodsNetOfReserves


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value2628262220182119161313
Percentage of InventoryFinishedGoodsNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves

us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value3191000.05411000.04176000.03597000.03124000.03962000.04092000.02778000.02441000.02275000.01471000.0
Percentage of InventoryRawMaterialsAndPurchasedPartsNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryWorkInProcessNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1453000.01663000.01870000.02012000.03118000.03174000.03166000.03303000.02756000.02830000.01877000.0
Percentage of InventoryWorkInProcessNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


None
Period End2020-06-30
Value12
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths


None
Period End2020-06-30
Value2840000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour


None
Period End2020-06-30
Value2002000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFour100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree


None
Period End2020-06-30
Value2096000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearThree100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo


None
Period End2020-06-30
Value2621000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearTwo100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear


None
Period End2020-06-30
Value1486000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear100.0

us-gaap:LineOfCredit us-gaap:LineOfCreditFacility

us-gaap:LineOfCredit

atnx:ChongqingMaliuRiversideDevelopmentAndInvestmentCoLTD


None
Period End2020-06-302020-03-312019-12-31
Value6636000.06055000.05731000.0
Percentage of LineOfCredit100.0100.0100.0

us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity us-gaap:DebtInstrument, us-gaap:TypeOfArrangement

us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity

atnx:TrancheA, atnx:SeniorCreditAgreement


None
Period End2020-06-30
Value100
Percentage of LineOfCreditFacilityCurrentBorrowingCapacity100.0

us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity us-gaap:LineOfCreditFacility

atnx:ChongqingMaliuRiversideDevelopmentAndInvestmentCoLTD


None
Period End2020-06-30
Value1.0
Percentage of LineOfCreditFacilityCurrentBorrowingCapacity1.0

us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity us-gaap:TypeOfArrangement

atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value100
Percentage of LineOfCreditFacilityCurrentBorrowingCapacity0.0

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity us-gaap:LineOfCreditFacility, us-gaap:StatementGeographical

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity

atnx:ChongqingMaliuRiversideDevelopmentAndInvestmentCoLTD, country:CN


None
Period End2020-03-312019-12-312019-06-30
Value7.27.250
Percentage of LineOfCreditFacilityMaximumBorrowingCapacity100.0100.0100.0

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity us-gaap:StatementGeographical, us-gaap:LineOfCreditFacility

country:CN, atnx:ChongqingMaliuRiversideDevelopmentAndInvestmentCoLTD


None
Period End2020-06-302019-06-30
Value7.250
Percentage of LineOfCreditFacilityMaximumBorrowingCapacity0.0100.0

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity us-gaap:TypeOfArrangement

atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value225
Percentage of LineOfCreditFacilityMaximumBorrowingCapacity0.0

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity us-gaap:DebtInstrument, us-gaap:TypeOfArrangement

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity

atnx:TrancheB, atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value25
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity100.0

atnx:TrancheC, atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value25
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity100.0

atnx:TrancheD, atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value25
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity100.0

atnx:TrancheE, atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value50
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity200.0

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity us-gaap:TypeOfArrangement

atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value125
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity500.0

us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent

us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1107000.0871000.0880000.0958000.01685000.01720000.0961000.0978000.01050000.01037000.01015000.0842000.0832000.0766000.0
Percentage of LongTermDebtAndCapitalLeaseObligationsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LongTermDebtPercentageBearingFixedInterestRate us-gaap:TypeOfArrangement

us-gaap:LongTermDebtPercentageBearingFixedInterestRate

atnx:SeniorCreditAgreement


None
Period End2020-06-19
Value0.11
Percentage of LongTermDebtPercentageBearingFixedInterestRate100.0

us-gaap:RestrictedCashCurrent

us-gaap:RestrictedCashCurrent


None
Period End2020-06-302019-09-302019-06-30
Value112525
Percentage of RestrictedCashCurrent100.0100.0100.0

us-gaap:RestrictedCashCurrent us-gaap:DebtInstrument

atnx:SeniorCreditAgreement


None
Period End2020-06-30
Value11
Percentage of RestrictedCashCurrent100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue


None
Period End2020-06-302019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value53693712339447511396881129943
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockShares

us-gaap:TreasuryStockShares


None
Period End2020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value1672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01672900.01656900.0
Percentage of TreasuryStockShares100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Line plots across dimensions of each concept


us-gaap:SharesOutstanding
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities
(None,)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments, us-gaap:ConsolidationItems
(None, 'us-gaap:OperatingSegments')
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
(None,)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical, us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments
('country:US', 'us-gaap:TransferredAtPointInTime', None)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical, us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments
(None, 'us-gaap:TransferredAtPointInTime', 'atnx:GlobalSupplyChainPlatform')
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TimingOfTransferOfGoodOrService, us-gaap:StatementBusinessSegments
('us-gaap:TransferredAtPointInTime', None)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:OperatingSegments', None)
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'atnx:GlobalSupplyChainPlatform', 'us-gaap:TransferredAtPointInTime')
None
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')
None
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
None
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
None
us-gaap:ProfitLoss
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:NetIncomeLoss
us-gaap:StatementBusinessSegments
(None,)
None
us-gaap:Assets
us-gaap:StatementBusinessSegments
(None,)
None
us-gaap:AccountsReceivableNetCurrent
us-gaap:StatementBusinessSegments
(None,)
None
us-gaap:PropertyPlantAndEquipmentNet
us-gaap:StatementGeographical
(None,)
None
us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)
None
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:NetIncomeLoss
us-gaap:StatementBusinessSegments
(None,)
None
us-gaap:ProfitLoss
us-gaap:StatementEquityComponents
(None,)
None
us-gaap:DepreciationDepletionAndAmortization
us-gaap:StatementBusinessSegments
(None,)
None